<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xml:lang="EN" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//ACS//DTD ACS Journal DTD v1.02 20061031//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName ACSJournal-v102.dtd?><?SourceDTD.Version 1.02?><?ConverterInfo.XSLTName acs2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">ACS Chem Biol</journal-id><journal-id journal-id-type="iso-abbrev">ACS Chem Biol</journal-id><journal-id journal-id-type="publisher-id">cb</journal-id><journal-id journal-id-type="coden">acbcct</journal-id><journal-title-group><journal-title>ACS Chemical Biology</journal-title></journal-title-group><issn pub-type="ppub">1554-8929</issn><issn pub-type="epub">1554-8937</issn><publisher><publisher-name>American Chemical
Society</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">8291499</article-id><article-id pub-id-type="pmid">33913701</article-id><article-id pub-id-type="doi">10.1021/acschembio.1c00170</article-id><article-categories><subj-group><subject>Articles</subject></subj-group></article-categories><title-group><article-title>Genomic-Led Discovery of a Novel Glycopeptide Antibiotic
by <italic>Nonomuraea coxensis</italic> DSM 45129</article-title></title-group><contrib-group><contrib contrib-type="author" id="ath1"><contrib-id contrib-id-type="orcid" authenticated="true">http://orcid.org/0000-0003-3296-8297</contrib-id><name><surname>Yushchuk</surname><given-names>Oleksandr</given-names></name><xref rid="aff1" ref-type="aff">&#x000a7;</xref></contrib><contrib contrib-type="author" id="ath2"><name><surname>Vior</surname><given-names>Natalia M.</given-names></name><xref rid="aff2" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" id="ath3"><name><surname>Andreo-Vidal</surname><given-names>Andres</given-names></name><xref rid="aff1" ref-type="aff">&#x000a7;</xref></contrib><contrib contrib-type="author" id="ath4"><name><surname>Berini</surname><given-names>Francesca</given-names></name><xref rid="aff1" ref-type="aff">&#x000a7;</xref></contrib><contrib contrib-type="author" id="ath5"><name><surname>R&#x000fc;ckert</surname><given-names>Christian</given-names></name><xref rid="aff3" ref-type="aff">&#x02021;</xref></contrib><contrib contrib-type="author" id="ath6"><name><surname>Busche</surname><given-names>Tobias</given-names></name><xref rid="aff3" ref-type="aff">&#x02021;</xref></contrib><contrib contrib-type="author" id="ath7"><name><surname>Binda</surname><given-names>Elisa</given-names></name><xref rid="aff1" ref-type="aff">&#x000a7;</xref></contrib><contrib contrib-type="author" id="ath8"><name><surname>Kalinowski</surname><given-names>J&#x000f6;rn</given-names></name><xref rid="aff3" ref-type="aff">&#x02021;</xref></contrib><contrib contrib-type="author" corresp="yes" id="ath9"><contrib-id contrib-id-type="orcid" authenticated="true">http://orcid.org/0000-0001-5453-7485</contrib-id><name><surname>Truman</surname><given-names>Andrew W.</given-names></name><xref rid="cor1" ref-type="other">*</xref><xref rid="aff2" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" corresp="yes" id="ath10"><contrib-id contrib-id-type="orcid" authenticated="true">http://orcid.org/0000-0001-9195-6777</contrib-id><name><surname>Marinelli</surname><given-names>Flavia</given-names></name><xref rid="cor2" ref-type="other">*</xref><xref rid="aff1" ref-type="aff">&#x000a7;</xref></contrib><aff id="aff1"><label>&#x000a7;</label>Department
of Biotechnology and Life Sciences, <institution>University
of Insubria</institution>, via J. H. Dunant 3, 21100 Varese, <country>Italy</country></aff><aff id="aff2"><label>&#x02020;</label>Department
of Molecular Microbiology, <institution>John Innes Centre</institution>, Norwich, NR4 7UH, <country>United Kingdom</country></aff><aff id="aff3"><label>&#x02021;</label>Technology
Platform Genomics, CeBiTec, <institution>Bielefeld University</institution>, Sequenz 1, 33615 Bielefeld, <country>Germany</country></aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>For chemistry email: <email>andrew.truman@jic.ac.uk</email>.</corresp><corresp id="cor2"><label>*</label>For microbiology email: <email>flavia.marinelli@uninsubria.it</email>.</corresp></author-notes><pub-date pub-type="epub"><day>29</day><month>04</month><year>2021</year></pub-date><pub-date pub-type="ppub"><day>21</day><month>05</month><year>2021</year></pub-date><volume>16</volume><issue>5</issue><fpage>915</fpage><lpage>928</lpage><history><date date-type="received"><day>08</day><month>03</month><year>2021</year></date><date date-type="accepted"><day>14</day><month>04</month><year>2021</year></date></history><permissions><copyright-statement>&#x000a9; 2021 The Authors. Published by American
Chemical Society</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>The Authors</copyright-holder><license><license-p>Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p content-type="toc-graphic"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cb1c00170_0006" id="ab-tgr1"/></p><p>Glycopeptide antibiotics
(GPAs) are last defense line drugs against
multidrug-resistant Gram-positive pathogens. Natural GPAs teicoplanin
and vancomycin, as well as semisynthetic oritavancin, telavancin,
and dalbavancin, are currently approved for clinical use. Although
these antibiotics remain efficient, emergence of novel GPA-resistant
pathogens is a question of time. Therefore, it is important to investigate
the natural variety of GPAs coming from so-called &#x0201c;rare&#x0201d;
actinobacteria. Herein we describe a novel GPA producer&#x02014;<italic>Nonomuraea coxensis</italic> DSM 45129. Its <italic>de novo</italic> sequenced and completely assembled genome harbors a biosynthetic
gene cluster (BGC) similar to the <italic>dbv</italic> BGC of A40926,
the natural precursor to dalbavancin. The strain produces a novel
GPA, which we propose is an A40926 analogue lacking the carboxyl group
on the <italic>N</italic>-acylglucosamine moiety. This structural
difference correlates with the absence of <italic>dbv29</italic>&#x02014;coding
for an enzyme responsible for the oxidation of the <italic>N</italic>-acylglucosamine moiety. Introduction of <italic>dbv29</italic> into <italic>N. coxensis</italic> led to A40926 production in this strain.
Finally, we successfully applied <italic>dbv3</italic> and <italic>dbv4</italic> heterologous transcriptional regulators to trigger
and improve A50926 production in <italic>N. coxensis</italic>, making them prospective tools for screening other <italic>Nonomuraea</italic> spp. for GPA production. Our work highlights
genus <italic>Nonomuraea</italic> as a still untapped
source of novel GPAs.</p></abstract><funding-group><award-group><funding-source><institution-wrap><institution>Biotechnology and Biological Sciences Research Council</institution><institution-id institution-id-type="doi">10.13039/501100000268</institution-id></institution-wrap></funding-source><award-id>BBS/E/J/000PR9790</award-id></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution>Royal Society</institution><institution-id institution-id-type="doi">10.13039/501100000288</institution-id></institution-wrap></funding-source><award-id>NA</award-id></award-group></funding-group><custom-meta-group><custom-meta><meta-name>document-id-old-9</meta-name><meta-value>cb1c00170</meta-value></custom-meta><custom-meta><meta-name>document-id-new-14</meta-name><meta-value>cb1c00170</meta-value></custom-meta><custom-meta><meta-name>ccc-price</meta-name><meta-value/></custom-meta></custom-meta-group></article-meta></front><body><sec id="sec1"><label>1</label><title>Introduction</title><p><italic>Nonomuraea</italic> is a genus of so-called
&#x0201c;rare&#x0201d; actinomycetes whose potential to produce specialized
(secondary) metabolites is still rather poorly explored.<sup><xref ref-type="bibr" rid="ref1">1</xref>,<xref ref-type="bibr" rid="ref2">2</xref></sup> Recently sequenced genomes of <italic>Nonomuraea</italic> species appear to be generally larger than the reference <italic>Streptomyces</italic> ones. The mean genome size of <italic>Nonomuraea</italic> (based on the three available complete
assemblies<sup><xref ref-type="bibr" rid="ref2">2</xref>,<xref ref-type="bibr" rid="ref3">3</xref></sup>) is around 12 Mbp, whereas the mean genome
size of <italic>Streptomyces</italic> (calculated on
251 fully assembled genomes available in GenBank) equals 8.6 Mbp.
The larger genomes of <italic>Nonomuraea</italic> spp.
encode dozens of putative biosynthetic gene clusters (BGCs).<sup><xref ref-type="bibr" rid="ref2">2</xref>&#x02212;<xref ref-type="bibr" rid="ref4">4</xref></sup><italic>Nonomuraea</italic> spp. were initially found
to be recalcitrant to commonly used genetic engineering manipulations,
but new tools are now being developed for this genus.<sup><xref ref-type="bibr" rid="ref5">5</xref>&#x02212;<xref ref-type="bibr" rid="ref7">7</xref></sup> This paves the way for unravelling the huge hidden biosynthetic
potential of these organisms.</p><p>Probably the most important bioactive
metabolite produced by a <italic>Nonomuraea</italic> species is the type IV<sup><xref ref-type="bibr" rid="ref8">8</xref></sup> glycopeptide
antibiotic (GPA) A40926<sup><xref ref-type="bibr" rid="ref9">9</xref></sup> (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>) produced by <italic>Nonomuraea gerenzanensis</italic> ATCC 39727. Like other GPAs,
A40926 acts as a selective and potent
inhibitor of cell-wall biosynthesis in Gram-positive bacteria. A40926
is structurally related to the clinically relevant GPA teicoplanin
(<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>), produced
by <italic>Actinoplanes teichomyceticus</italic> ATCC
31121<sup><xref ref-type="bibr" rid="ref10">10</xref>,<xref ref-type="bibr" rid="ref11">11</xref></sup> and to ristocetin (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>), previously isolated from numerous <italic>Amycolatopsis</italic> spp. (i.e., <italic>A. lurida</italic> NRRL 2430, <italic>A. japonicum</italic> MG417-CF17,
and <italic>Amycolatopsis</italic> sp. MJM2582).<sup><xref ref-type="bibr" rid="ref12">12</xref>&#x02212;<xref ref-type="bibr" rid="ref14">14</xref></sup> Like teicoplanin, A40926 is produced as a mixture of related compounds
(major components are A40926 B and A40926 A factors), which differ
in the length and branching of an aliphatic side chain (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>). It was recently clarified
that <italic>N. gerenzanensis</italic> produces the
GPA in the form of <italic>O</italic>-acetyl-A40926 (with an <italic>O</italic>-acetylated mannose residue), but the acetyl group is lost
during the alkaline extraction of the antibiotic.<sup><xref ref-type="bibr" rid="ref15">15</xref>,<xref ref-type="bibr" rid="ref16">16</xref></sup> Since it was this deacetylated GPA that was initially named A40926,
we will refer to it as A40926 hereafter.</p><fig id="fig1" position="float"><label>Figure 1</label><caption><p>Structures of the GPAs
found in genus <italic>Nonomuraea</italic>: type IV
A40926 and type V kistamicin. Clinically used dalbavancin
is obtained from A40926 by conversion of the C-terminal carboxyl group
into a (3-dimethylamino)-1-propylamide. Type IV teicoplanin and type
III ristocetin are shown due to their structural similarities with
A40926. For teicoplanin, the main factor (TA<sub>2&#x02013;2</sub>)
of the complex produced by <italic>A. teichomyceticus</italic> is shown, the other factors are differing by the length and branching
of the lipid chain. Ristocetin is produced by numerous <italic>Amycolatopsis</italic> species.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cb1c00170_0009" id="GRAPHIC-d7e435-autogenerated" position="float"/></fig><p>A40926
is the precursor of the second-generation semisynthetic
GPA dalbavancin (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>), which is currently applied in clinics to treat severe infections
caused by multidrug-resistant Gram-positive pathogens.<sup><xref ref-type="bibr" rid="ref17">17</xref></sup> Dalbavancin (marketed in Europe and USA under
the trade names xydalba and dalvance, respectively) is the first antibiotic
designated as a qualified infectious disease product by FDA because
of its potency, extended dosing interval, and unique dose regimen
(once-a-week), but its cost still largely exceeds that of first-generation
GPAs.<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> Therefore, improvement of A40926
production by recombinant engineering of <italic>N. gerenzanensis</italic> has become increasingly relevant.<sup><xref ref-type="bibr" rid="ref6">6</xref>,<xref ref-type="bibr" rid="ref16">16</xref></sup> Following
the sequencing of the A40926 BGC (<italic>dbv</italic>) almost two
decades ago,<sup><xref ref-type="bibr" rid="ref18">18</xref></sup> multiple aspects of A40926
biosynthesis were investigated, including nonribosomal aglycone assembly
and tailoring steps,<sup><xref ref-type="bibr" rid="ref15">15</xref>,<xref ref-type="bibr" rid="ref19">19</xref>,<xref ref-type="bibr" rid="ref20">20</xref></sup> self-resistance,<sup><xref ref-type="bibr" rid="ref21">21</xref>,<xref ref-type="bibr" rid="ref22">22</xref></sup> and pathway-specific regulation
of its production.<sup><xref ref-type="bibr" rid="ref6">6</xref>,<xref ref-type="bibr" rid="ref23">23</xref>,<xref ref-type="bibr" rid="ref24">24</xref></sup><italic>N. gerenzanensis</italic> was also engineered
to produce A40926 derivatives that are better suited for downstream
chemical modification to dalbavancin.<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> Another GPA produced by a <italic>Nonomuraea</italic> species is the type V GPA kistamicin (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>) from <italic>Nonomuraea</italic> sp. ATCC 55076, which was reported to exhibit potent antiviral activity
as well as mild antibiosis against Gram-positive bacteria.<sup><xref ref-type="bibr" rid="ref2">2</xref>,<xref ref-type="bibr" rid="ref25">25</xref></sup> Its structure contains an unusual indole&#x02013;phenol cross-link
which makes this GPA unique among those already known.<sup><xref ref-type="bibr" rid="ref5">5</xref>,<xref ref-type="bibr" rid="ref26">26</xref></sup></p><p>Genome mining has recently shown that other species from the
genus <italic>Nonomuraea</italic> also possess BGCs
for GPAs,<sup><xref ref-type="bibr" rid="ref27">27</xref></sup> as in the cases of <italic>Nonomuraea</italic> sp. WAC 01424 and <italic>Nonomuraea
coxensis</italic> DSM 45129. Notwithstanding the low quality
of the available draft
genomic data, we recently showed that <italic>N. coxensis</italic> DSM 45129 carries a BGC remarkably similar to <italic>dbv</italic>.<sup><xref ref-type="bibr" rid="ref6">6</xref></sup> We found that this BGC contains a putative
regulatory gene orthologous to <italic>dbv3</italic>, which encodes
the pathway-specific regulator of LuxR-type in <italic>N. gerenzanensis</italic>.<sup><xref ref-type="bibr" rid="ref6">6</xref></sup> The heterologous expression of this
gene from <italic>N. coxensis</italic> (named <italic>nocRI</italic>) led to A40926 overproduction in <italic>N.
gerenzanensis</italic>, indicating that it might be functional
in <italic>N. coxensis</italic> as well. Thus, in this
paper we present the fully assembled genome of <italic>N. coxensis</italic>, which has allowed us to properly describe the putative GPA BGC
(called <italic>noc</italic>). Additionally, we report that <italic>N. coxensis</italic> produces a novel GPA complex, which we
named A50926. Structural characterization of A50926 by liquid chromatography&#x02013;mass
spectrometry (LC-MS) and tandem MS (MS/MS) showed it has high similarity
to A40926, although A50926 lacks the carboxyl group on the <italic>N</italic>-acylglucosamine (Glc<italic>N</italic>-Acyl) moiety. Consistently,
the <italic>noc</italic> BGC lacks an orthologue of <italic>dbv29</italic>, which in <italic>N. gerenzanensis</italic> encodes
the enzyme oxidizing the Glc<italic>N</italic>-Acyl moiety to an <italic>N-</italic>acylaminoglucuronic group.<sup><xref ref-type="bibr" rid="ref19">19</xref></sup> Introduction of <italic>dbv29</italic> into <italic>N. coxensis</italic> changed the GPA production profile of this strain to A40926. Finally,
we have introduced <italic>dbv3</italic> and <italic>dbv4</italic> pathway-specific regulatory genes in <italic>N. coxensis</italic> to trigger and overproduce A50926 by regulatory gene cross-talking.
In conclusion, our results describe the biosynthesis of a novel GPA,
which may have superior properties to A40926<sup><xref ref-type="bibr" rid="ref28">28</xref></sup> and thus may contribute to developing a platform for the combinatorial
biosynthesis of third generation lipo-GPAs.</p></sec><sec id="sec2"><label>2</label><title>Results
and Discussion</title><sec id="sec2.1"><label>2.1</label><title>Complete Assembly of <italic>N. coxensis</italic> Genome Reveals the Presence of a Novel
GPA BGC</title><p>The presence
of a novel GPA BGC in the genome of <italic>N. coxensis</italic> was recently anticipated.<sup><xref ref-type="bibr" rid="ref6">6</xref>,<xref ref-type="bibr" rid="ref27">27</xref></sup> However, due to the
poor quality of the available draft, fragments of the BGC were found
on different contigs and did not cover the full expected sequence
of the BGC. Therefore, we sequenced and fully assembled the genome
of <italic>N. coxensis</italic> DSM 45129 using a combination
of HiSeq Illumina and GridION ONT technologies. The circular chromosome
of <italic>N. coxensis</italic> was found to have a
smaller size in comparison to the other two previously published <italic>Nonomuraea</italic> genomes&#x02014;only 9.07 Mbp compared
to 11.85 Mbp in <italic>N. gerenzanensis</italic>(<xref ref-type="bibr" rid="ref3">3</xref>) and 13.05 Mbp in <italic>Nonomuraea</italic> sp. ATCC 55076.<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> The average GC-content
was 71.8%. Annotation of the <italic>N. coxensis</italic> genome revealed 8398 predicted protein coding sequences, five operons
for 16S-23S-5S rRNA, and 73 tRNA genes. Genome analysis by antiSMASH
5.0,<sup><xref ref-type="bibr" rid="ref29">29</xref></sup> a specialized metabolite BGC identification
tool, led to the discovery of 27 putative BGCs when used in the &#x0201c;relaxed&#x0201d;
search mode. However, only a few BGCs showed more than 20% similarity
to known BGCs (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschembio.1c00170/suppl_file/cb1c00170_si_001.pdf">Table S1</ext-link>).</p><p>We thus
focused our attention on the GPA-like BGC, which we denoted as <italic>noc</italic> (from <italic><bold>No</bold>nomuraea<bold>c</bold>oxensis</italic>). The <italic>noc</italic> BGC is the fourth GPA BGC described from <italic>Nonomuraea</italic> genus, following the <italic>dbv</italic> BGC from <italic>N. gerenzanensis</italic>,<sup><xref ref-type="bibr" rid="ref18">18</xref></sup> a putative GPA BGC from <italic>Nonomuraea</italic> sp. WAC 01424<sup><xref ref-type="bibr" rid="ref27">27</xref></sup> and the type V GPA kistamicin
(<italic>kis</italic>) BGC from <italic>Nonomuraea</italic> sp. ATCC 55076.<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> Overall, <italic>noc</italic> contains 36 open reading frames (ORFs) with 35 among them homologous
to <italic>dbv</italic> genes (the nonhomologous <italic>noc</italic> gene encoding for a putative transposase) and 32 being homologous
to genes in the <italic>Nonomuraea</italic> sp. WAC
01424 GPA BGC (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>, <xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>). The <italic>kis</italic> BGC differed from <italic>noc</italic> most significantly
(data not shown).</p><fig id="fig2" position="float"><label>Figure 2</label><caption><p>Comparison of BGCs from <italic>N. gerenzanensis</italic> (<italic>dbv</italic>), <italic>N. coxensis</italic> (<italic>noc</italic>), and <italic>Nonomuraea</italic> sp. WAC 01424. Colored lines indicate the homology segments among
the BGCs. For <italic>dbv</italic> and <italic>noc</italic>, the orientation
of the BGC genes is in relation to the orientation of the <italic>dnaA</italic> gene of the chromosome. This orientation was not possible
for the WAC 01424 GPA BGC, since the corresponding genome is fragmented
across multiple contigs. Details on gene function and homology are
given in <xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref> and
in the main text.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cb1c00170_0001" id="gr2" position="float"/></fig><table-wrap id="tbl1" position="float"><label>Table 1</label><caption><title>Characterization
of <italic>noc</italic> BGC genes and their comparison to the <italic>dbv</italic> and WAC
01424 GPA BGCs from <italic>Nonomuraea</italic> spp.</title></caption><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="left"/><col align="left"/><col align="left"/></colgroup><thead><tr><th style="border:none;" align="center"><italic>noc</italic> BGC genes</th><th style="border:none;" align="center">homologues
from <italic>dbv</italic> BGC (aa identity of protein product with <italic>noc</italic> homologue, %)</th><th style="border:none;" align="center">homologues
from WAC 01424 GPA BGC (numbered as in <xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>) (aa identity of protein product with <italic>noc</italic> homologue, %)</th><th style="border:none;" align="center">encoded protein</th></tr></thead><tbody><tr><td style="border:none;" align="left"><italic>noc1</italic></td><td style="border:none;" align="left"><italic>dbv1</italic> (90.6%)</td><td style="border:none;" align="left"><italic>DMB42_RS42735</italic> (31) (60%)</td><td style="border:none;" align="left">hydroxymandelate
oxidase
(Hmo)</td></tr><tr><td style="border:none;" align="left"><italic>noc2</italic></td><td style="border:none;" align="left"><italic>dbv2</italic> (89.3%)</td><td style="border:none;" align="left"><italic>DMB42_RS42740</italic> (30) (62%)</td><td style="border:none;" align="left">hydroxymandelate synthase
(HmaS)</td></tr><tr><td style="border:none;" align="left"><italic>noc3</italic></td><td style="border:none;" align="left"><italic>dbv37</italic> (90.9%)</td><td style="border:none;" align="left"><italic>DMB42_RS42745</italic> (29) (83%)</td><td style="border:none;" align="left">hydroxyphenylglycine aminotransferase
(HpgT)</td></tr><tr><td style="border:none;" align="left"><italic>noc4</italic></td><td style="border:none;" align="left"><italic>dbv35</italic> (90.9%)</td><td style="border:none;" align="left"><italic>DMB42_RS42730</italic> (32) (63%)</td><td style="border:none;" align="left">Na<sup>+</sup>&#x02013;H<sup>+</sup> antiporter</td></tr><tr><td style="border:none;" align="left"><italic>noc5</italic></td><td style="border:none;" align="left"><italic>dbv34</italic> (93.9%)</td><td style="border:none;" align="left"><italic>DMB42_RS42710</italic> (36) (87%)</td><td style="border:none;" align="left">enoyl-CoA hydratase (DpgD)</td></tr><tr><td style="border:none;" align="left"><italic>noc6</italic></td><td style="border:none;" align="left"><italic>dbv33</italic> (89.2%)</td><td style="border:none;" align="left"><italic>DMB42_RS42715</italic> (35) (84%)</td><td style="border:none;" align="left">dihydroxyphenylacetyl-CoA
dioxygenase (DpgC)</td></tr><tr><td style="border:none;" align="left"><italic>noc7</italic></td><td style="border:none;" align="left"><italic>dbv32</italic> (85.1%)</td><td style="border:none;" align="left"><italic>DMB42_RS42720</italic> (34) (74%)</td><td style="border:none;" align="left">enoyl-CoA hydratase (DpgB)</td></tr><tr><td style="border:none;" align="left"><italic>noc8</italic></td><td style="border:none;" align="left"><italic>dbv31</italic> (94.3%)</td><td style="border:none;" align="left"><italic>DMB42_RS42725</italic> (33) (91%)</td><td style="border:none;" align="left">type III polyketide synthase
(DpgA)</td></tr><tr><td style="border:none;" align="left"><italic>noc9</italic></td><td style="border:none;" align="left"><italic>dbv30</italic> (83.5%)</td><td style="border:none;" align="left"><italic>DMB42_RS42750</italic> (28) (69%)</td><td style="border:none;" align="left">4HB-CoA thioesterase</td></tr><tr><td style="border:none;" align="left"><italic>noc10</italic></td><td style="border:none;" align="left"><italic>dbv28</italic> (92.4%)</td><td style="border:none;" align="left"><italic>DMB42_RS42760</italic> (26) (86%)</td><td style="border:none;" align="left">&#x003b2;-hydroxylase</td></tr><tr><td style="border:none;" align="left"><italic>noc11</italic></td><td style="border:none;" align="left"><italic>dbv27</italic> (91.8%)</td><td style="border:none;" align="left"><italic>DMB42_RS42755</italic> (27) (58%)</td><td style="border:none;" align="left">methyltransferase</td></tr><tr><td style="border:none;" align="left"><italic>noc12</italic></td><td style="border:none;" align="left"><italic>dbv18</italic> (87.3%)</td><td style="border:none;" align="left"><xref rid="t1fn1" ref-type="table-fn">a</xref></td><td style="border:none;" align="left">ABC transporter</td></tr><tr><td style="border:none;" align="left"><italic>noc13</italic></td><td style="border:none;" align="left"><italic>dbv19</italic> (92.2%)</td><td style="border:none;" align="left"><xref rid="t1fn1" ref-type="table-fn">a</xref></td><td style="border:none;" align="left">ABC transporter</td></tr><tr><td style="border:none;" align="left"><italic>noc14</italic></td><td style="border:none;" align="left"><italic>dbv20</italic> (89.7%)</td><td style="border:none;" align="left"><xref rid="t1fn1" ref-type="table-fn">a</xref></td><td style="border:none;" align="left">mannosyltransferase</td></tr><tr><td style="border:none;" align="left"><italic>noc15</italic></td><td style="border:none;" align="left"><italic>dbv21</italic> (86.6%)</td><td style="border:none;" align="left"><italic>DMB42_RS</italic>42765 (25) (64%)</td><td style="border:none;" align="left">deacetylase</td></tr><tr><td style="border:none;" align="left"><italic>noc16</italic></td><td style="border:none;" align="left"><italic>dbv22</italic> (92.3%)</td><td style="border:none;" align="left"><italic>DMB42_RS</italic>42850 (9) (77%)</td><td style="border:none;" align="left">sensory histidine kinase</td></tr><tr><td style="border:none;" align="left"><italic>noc17</italic></td><td style="border:none;" align="left"><italic>dbv23</italic> (88.1%)</td><td style="border:none;" align="left"><xref rid="t1fn1" ref-type="table-fn">a</xref></td><td style="border:none;" align="left">acetyltransferase</td></tr><tr><td style="border:none;" align="left"><italic>noc18</italic></td><td style="border:none;" align="left"><italic>dbv24</italic> (92.4%)</td><td style="border:none;" align="left"><italic>DMB42_RS42845</italic> (10) (81%)</td><td style="border:none;" align="left">ABC transporter</td></tr><tr><td style="border:none;" align="left"><italic>nocA</italic></td><td style="border:none;" align="left"><italic>dbv25</italic> (88.7%)</td><td style="border:none;" align="left"><italic>DMB42_RS42840</italic> (11) (76%)</td><td style="border:none;" align="left">NRPS modules 1&#x02013;2</td></tr><tr><td style="border:none;" align="left"><italic>nocB</italic></td><td style="border:none;" align="left"><italic>dbv26</italic> (91%)</td><td style="border:none;" align="left"><italic>DMB42_RS42835</italic> (12) (78%)</td><td style="border:none;" align="left">NRPS module&#x000a0;3</td></tr><tr><td style="border:none;" align="left"><italic>nocC</italic></td><td style="border:none;" align="left"><italic>dbv17</italic> (89.6%)</td><td style="border:none;" align="left"><italic>DMB42_RS42830</italic> (13) (77%)</td><td style="border:none;" align="left">NRPS modules&#x000a0;4&#x02013;5&#x02013;6</td></tr><tr><td style="border:none;" align="left"><italic>nocD</italic></td><td style="border:none;" align="left"><italic>dbv16</italic> (91.7%)</td><td style="border:none;" align="left"><italic>DMB42_RS42825</italic> (14) (79%)</td><td style="border:none;" align="left">NRPS module&#x000a0;7</td></tr><tr><td style="border:none;" align="left"><italic>noc19</italic></td><td style="border:none;" align="left"><italic>dbv15</italic> (94.2%)</td><td style="border:none;" align="left"><italic>DMB42_RS42820</italic> (15) (93%)</td><td style="border:none;" align="left">MbtH-like protein</td></tr><tr><td style="border:none;" align="left"><italic>noc20</italic></td><td style="border:none;" align="left"><italic>dbv14</italic> (91.8%)</td><td style="border:none;" align="left"><italic>DMB42_RS42815</italic> (16) (78%)</td><td style="border:none;" align="left">cross-linking oxygenase
(OxyA)</td></tr><tr><td style="border:none;" align="left"><italic>noc21</italic></td><td style="border:none;" align="left"><italic>dbv13</italic> (89.8%)</td><td style="border:none;" align="left"><italic>DMB42_RS42810</italic> (17) (77%)</td><td style="border:none;" align="left">cross-linking oxygenase
(OxyC)</td></tr><tr><td style="border:none;" align="left"><italic>noc22</italic></td><td style="border:none;" align="left"><italic>dbv12</italic> (93.5%)</td><td style="border:none;" align="left"><italic>DMB42_RS42805</italic> (18) (77%)</td><td style="border:none;" align="left">cross-linking oxygenase
(OxyB)</td></tr><tr><td style="border:none;" align="left"><italic>noc23</italic></td><td style="border:none;" align="left"><italic>dbv11</italic> (91.9%)</td><td style="border:none;" align="left"><italic>DMB42_RS42795</italic> (20) (78%)</td><td style="border:none;" align="left">cross-linking oxygenase
(OxyE)</td></tr><tr><td style="border:none;" align="left"><italic>noc24</italic></td><td style="border:none;" align="left"><italic>dbv10</italic> (94.1%)</td><td style="border:none;" align="left"><italic>DMB42_RS42790</italic> (21) (87%)</td><td style="border:none;" align="left">halogenase</td></tr><tr><td style="border:none;" align="left"><italic>noc25</italic></td><td style="border:none;" align="left"><italic>dbv9</italic> (90.4%)</td><td style="border:none;" align="left"><italic>DMB42_RS42780</italic> (23) (74%)</td><td style="border:none;" align="left">glycosyltransferase
(GtfB)</td></tr><tr><td style="border:none;" align="left"><italic>noc26</italic></td><td style="border:none;" align="left"><italic>dbv8</italic> (87.5%)</td><td style="border:none;" align="left"><italic>DMB42_RS42775</italic> (24) (77%)</td><td style="border:none;" align="left">acyltransferase</td></tr><tr><td style="border:none;" align="left"><italic>noc27</italic></td><td style="border:none;" align="left"><italic>dbv7</italic> (87.3%)</td><td style="border:none;" align="left"><italic>DMB42_RS42865</italic> (6) (78%)</td><td style="border:none;" align="left">VanY-carboxypeptidase</td></tr><tr><td style="border:none;" align="left"><italic>noc28</italic></td><td style="border:none;" align="left"><italic>dbv6</italic> (95.9%)</td><td style="border:none;" align="left"><italic>DMB42_RS42855</italic> (8) (92%)</td><td style="border:none;" align="left">response
regulator</td></tr><tr><td style="border:none;" align="left"><italic>noc29</italic></td><td style="border:none;" align="left"><italic>dbv5</italic> (92.8%)</td><td style="border:none;" align="left"><italic>DMB42_RS42860</italic> (7) (85%)</td><td style="border:none;" align="left">prephenate dehydrogenase
(Pdh)</td></tr><tr><td style="border:none;" align="left"><italic>noc30</italic></td><td style="border:none;" align="left"><xref rid="t1fn1" ref-type="table-fn">a</xref></td><td style="border:none;" align="left"><xref rid="t1fn1" ref-type="table-fn">a</xref></td><td style="border:none;" align="left">putative transposase</td></tr><tr><td style="border:none;" align="left"><italic>nocRII</italic></td><td style="border:none;" align="left"><italic>dbv4</italic> (94.4%)</td><td style="border:none;" align="left"><italic>DMB42_RS42700</italic> (38) (85%)</td><td style="border:none;" align="left">StrR-like transcriptional
regulator</td></tr><tr><td style="border:none;" align="left"><italic>nocRI</italic></td><td style="border:none;" align="left"><italic>dbv3</italic> (86.3%)</td><td style="border:none;" align="left"><italic>DMB42_RS42695</italic> (39) (70%)</td><td style="border:none;" align="left">LuxR-like transcriptional
regulator</td></tr></tbody></table><table-wrap-foot><fn id="t1fn1"><label>a</label><p>Homologue is absent.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec2.2"><label>2.2</label><title>Comparative Genomics of <italic>Nonomuraea</italic> GPA Producers</title><p>At the time of
writing, genomic information
for 34 <italic>Nonomuraea</italic> species was available
in GenBank, although there are only three complete assemblies (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschembio.1c00170/suppl_file/cb1c00170_si_001.pdf">Table S2</ext-link>). Along with the four reported <italic>Nonomuraea</italic> GPA BGCs, we found a <italic>kis</italic>-like BGC in the draft genome of <italic>Nonomuraea</italic> sp. NN258 (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschembio.1c00170/suppl_file/cb1c00170_si_001.pdf">Figure S1</ext-link>). We have then reconstructed
the multilocus phylogeny (MLP) of all <italic>Nonomuraea</italic> species with available genomic data using conserved house-keeping
proteins (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschembio.1c00170/suppl_file/cb1c00170_si_001.pdf">Table S3</ext-link>). It revealed <italic>N. coxensis</italic> to be most closely related to <italic>N. wenchangensis</italic> CGMCC 4.5598, <italic>N.
polychroma</italic> DSM 43925, and <italic>N. turkmeniaca</italic> DSM 43926 (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschembio.1c00170/suppl_file/cb1c00170_si_001.pdf">Figure S2</ext-link>). None of these
species have GPA BGCs in their genomes. <italic>N. gerenzanensis</italic> is most closely related to <italic>Nonomuraea</italic> sp. FMUSA5&#x02013;5 and to the kistamicin producer <italic>Nonomuraea</italic> sp. ATCC 55076, whereas <italic>Nonomuraea</italic> sp. WAC 01424 is distantly related to
both <italic>N. coxensis</italic> and <italic>N. gerenzanensis</italic> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschembio.1c00170/suppl_file/cb1c00170_si_001.pdf">Figure S2</ext-link>). Thus, GPA-producing <italic>Nonomuraea</italic> species
do not form a single phylogenetic group, which is different from what
occurs in the majority of <italic>Amycolatopsis</italic> spp. producing GPAs.<sup><xref ref-type="bibr" rid="ref30">30</xref></sup></p><p>Since <italic>N. gerenzanensis</italic> and <italic>Nonomuraea</italic> sp. ATCC 55076 are closely related and their genomes had been completely
assembled, we compared their sequences using the MAUVE genome alignment
tool.<sup><xref ref-type="bibr" rid="ref31">31</xref></sup> We found that the two genomes are
very similar, having few rearranged homologous segments (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschembio.1c00170/suppl_file/cb1c00170_si_001.pdf">Figure S3A</ext-link>). Interestingly, the regions flanking
the <italic>dbv</italic> BGC in <italic>N. gerenzanensis</italic> show synteny in <italic>Nonomuraea</italic> sp. ATCC
55076, but in this genome, they flank a miscellaneous assemblage of
GPA-unrelated genes instead of the <italic>dbv</italic> genes. No <italic>dbv</italic>-like BGC is present in <italic>Nonomuraea</italic> sp. ATCC 55076. Similarly, no <italic>kis</italic>-like BGC is in
the <italic>N. gerenzanensis</italic> genome, but the
regions flanking the <italic>kis</italic> BGC in <italic>Nonomuraea</italic> sp. ATCC 55076 have their homologous counterparts in the <italic>N. gerenzanensis</italic> genome (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschembio.1c00170/suppl_file/cb1c00170_si_001.pdf">Figure S3A</ext-link>). Dot plots of <italic>N. gerenzanensis</italic> and <italic>Nonomuraea</italic> sp. ATCC 55076 confirm
the high homology between the two strains (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschembio.1c00170/suppl_file/cb1c00170_si_001.pdf">Figure S3B</ext-link>). A possible explanation is that <italic>Nonomuraea</italic> sp. ATCC 55076 and <italic>N. gerenzanensis</italic> genomes might have acquired different GPA BGCs independently through
horizontal gene transfer (HGT) events from other <italic>Nonomuraea</italic> (or not) species.</p><p>Dot plots of <italic>N. coxensis</italic> and <italic>Nonomuraea</italic> sp. ATCC 55076 genomes
(<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschembio.1c00170/suppl_file/cb1c00170_si_001.pdf">Figure S3C</ext-link>) as well as of <italic>N. coxensis</italic> and <italic>N. gerenzanensis</italic> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschembio.1c00170/suppl_file/cb1c00170_si_001.pdf">Figure S3D</ext-link>) indicate that <italic>N. coxensis</italic> is more distantly related to the other
GPA producing species. Unfortunately,
it was impossible to compare the genome of <italic>N. coxensis</italic> with its closest relatives <italic>N. wenchangensis</italic> CGMCC 4.5598, <italic>N. polychroma</italic> DSM 43925,
and <italic>N. turkmeniaca</italic> DSM 43926 (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschembio.1c00170/suppl_file/cb1c00170_si_001.pdf">Figure S2</ext-link>), due to the incompleteness of their
genome assemblies. Overall, it seems that the position of GPA BGCs
is not conserved within <italic>Nonomuraea</italic> genomes,
which contrasts to what was observed in most <italic>Amycolatopsis</italic> spp.<sup><xref ref-type="bibr" rid="ref30">30</xref></sup></p></sec><sec id="sec2.3"><label>2.3</label><title>Comparing <italic>noc</italic> and <italic>dbv</italic> Biosynthetic Pathways: From
Genes to Products</title><p>The biosynthesis of A40926 is well understood
(<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>). The heptapeptide
core of this antibiotic
is synthesized by a nonribosomal peptide synthetase (NRPS) assembly
line involving Dbv25, Dbv26, Dbv17, and Dbv16 proteins. The linear
peptide is cross-linked by four monooxygenases (Dbv14, Dbv12, Dbv13,
and Dbv11) and halogenated by Dbv10, giving the core aglycone. This
aglycone is further modified with the glycosyltransferases Dbv9 and
Dbv20, which attach <italic>N-</italic>acetyl glucosamine (Glc<italic>N</italic>Ac) and mannose, respectively.<sup><xref ref-type="bibr" rid="ref32">32</xref></sup> Then, Glc<italic>N</italic>Ac is oxidized by Dbv29, deacetylated
by Dbv21, and acylated by Dbv8. Finally, the mannose moiety is acetylated
by Dbv23, giving <italic>O</italic>-acetyl-A40926.</p><fig id="fig3" position="float"><label>Figure 3</label><caption><p>Conceptual scheme of
the biosynthesis of A40926 and of the GPA
(named A50926) from <italic>N. coxensis</italic>. Please
note the dashed acyl group at the mannose residue, which is installed
by Dbv23/Noc17 but consequentially lost during antibiotic extraction.
For more details and encoded protein names, please refer to the main
text and <xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cb1c00170_0002" id="gr3" position="float"/></fig><p>Considering the A40926 pathway, it was possible
to predict the
biosynthetic pathway of the putative GPA from <italic>N. coxensis</italic> (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>). Sets
of genes required for the biosynthesis of the nonproteinogenic precursor
amino acids 4-hydroxyphenylglycine (Hpg), 3,5-dihydroxyphenylglycine
(Dpg), and &#x003b2;-hydroxytyrosine (further used as substrates for
NRPS) are the same in <italic>noc</italic> and <italic>dbv</italic> BGCs (<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>, <xref rid="fig2" ref-type="fig">Figures <xref rid="fig2" ref-type="fig">2</xref></xref> and <xref rid="fig3" ref-type="fig">3</xref>). Next, the NRPS, encoded within <italic>noc</italic> BGC,
was found to have the same organization and A-domain specificities
as the <italic>dbv</italic> NRPS (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschembio.1c00170/suppl_file/cb1c00170_si_001.pdf">Figure S4, Table S4</ext-link>). All other genes, responsible for the cross-linking and
tailoring steps, were identical in both the <italic>noc</italic> and <italic>dbv</italic> pathways (<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>, <xref rid="fig2" ref-type="fig">Figures <xref rid="fig2" ref-type="fig">2</xref></xref> and <xref rid="fig3" ref-type="fig">3</xref>). However, one notable difference between <italic>dbv</italic> and <italic>noc</italic> was the absence of a <italic>dbv29</italic> orthologue in the latter. As mentioned above, Dbv29
is a hexose oxidase responsible for the oxidation of the Glc<italic>N</italic>-Acyl moiety of A40926.<sup><xref ref-type="bibr" rid="ref19">19</xref></sup> On
this basis, we predicted that the <italic>noc</italic> pathway might
produce an A40926 analogue lacking the carboxylic group on the Glc<italic>N</italic>-Acyl residue and therefore resembling teicoplanin in this
moiety (<xref rid="fig1" ref-type="fig">Figures <xref rid="fig1" ref-type="fig">1</xref></xref> and <xref rid="fig3" ref-type="fig">3</xref>).</p><p>Beyond the biosynthetic genes, <italic>noc</italic> and <italic>dbv</italic> feature homologous regulatory
genes. Two master regulators
of A40926 biosynthesis&#x02014;LuxR-like Dbv3 and StrR-like Dbv4&#x02014;have
orthologues coded within <italic>noc</italic>&#x02014;NocRI (94% aa
sequence identity) and NocRII (86% aa sequence identity), respectively.<sup><xref ref-type="bibr" rid="ref6">6</xref></sup> In <italic>N. gerenzanensis</italic>, both Dbv3 and Dbv4 are crucial for biosynthesis activation.<sup><xref ref-type="bibr" rid="ref23">23</xref></sup> Dbv4 was shown to bind the promoter regions
of operons <italic>dbv30-35</italic> (mainly coding for Dpg biosynthesis
enzymes) and <italic>dbv14-8</italic> (including the genes coding
for cross-linking monooxygenases), and its binding sites were identified.<sup><xref ref-type="bibr" rid="ref33">33</xref></sup> Our <italic>in silico</italic> analysis indicates
that identical binding sites are present in the promoter regions of <italic>noc20</italic> and <italic>noc8</italic>, orthologues of <italic>dbv14</italic> and <italic>dbv30</italic>, respectively (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschembio.1c00170/suppl_file/cb1c00170_si_001.pdf">Figure S5</ext-link>). DNA-binding sites of Dbv3 remain
uncharacterized, but its regulon was defined from gene expression
analysis and includes other biosynthetic genes and Dbv4.<sup><xref ref-type="bibr" rid="ref23">23</xref></sup> Given all these similarities, we presume that
NocRI/NocRII have functions identical to Dbv3/Dbv4 and both regulatory
pairs might cross-talk between these species. Our previous results,<sup><xref ref-type="bibr" rid="ref6">6</xref></sup> where heterologous expression of <italic>nocRI</italic> in <italic>N. gerenzanensis</italic> improved A40926
production, support this assumption. The single GPA resistance determinant
encoded within <italic>noc</italic> is Noc27, a close (87%) orthologue
of Dbv7 (VanY<sub>n</sub>), which is a <sc>d</sc>,<sc>d</sc>-carboxypeptidase
involved in A40926 self-resistance.<sup><xref ref-type="bibr" rid="ref21">21</xref>,<xref ref-type="bibr" rid="ref34">34</xref></sup></p><p>Although
the biosynthetic, regulatory, and resistance genes are
apparently shared by the <italic>dbv</italic> and <italic>noc</italic> BGCs, their genetic organization is different. So far, almost all
GPA BGCs have NRPS genes located on one strand in an order that is
colinear to the order of the modules in the NRPS assembly line. The
only exception is the <italic>dbv</italic> BGC, where the NRPS genes
are coded on different strands and are separated by other biosynthetic
genes.<sup><xref ref-type="bibr" rid="ref18">18</xref></sup> The <italic>noc</italic> BGC,
although sharing a remarkable similarity with <italic>dbv</italic>, features an organization of NRPS genes that is typical of all the
other GPAs. Interestingly, only two chromosomal inversion events are
needed to rearrange <italic>noc</italic> into <italic>dbv</italic> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschembio.1c00170/suppl_file/cb1c00170_si_001.pdf">Figure S6</ext-link>), indicating how a <italic>dbv-</italic>like gene arrangement might have derived from a <italic>noc-</italic>like BGC in a common ancestor of <italic>N. coxensis</italic> and <italic>N. gerenzanensis</italic> (or in an ancestralprotocluster).</p><p>The putative GPA BGC in <italic>Nonomuraea</italic> sp. WAC 01424 (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>) differs more substantially from both <italic>noc</italic> and <italic>dbv.</italic> It lacks a <italic>noc14/dbv20</italic> homologue encoding
for a mannosyltransferase, as well as a <italic>noc17/dbv23</italic> homologue encoding for a mannose-<italic>O-</italic>acetyltransferase
(<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>). Instead,
WAC 01424 GPA BGC contains a close homologue of <italic>staL</italic> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschembio.1c00170/suppl_file/cb1c00170_si_001.pdf">Figure S7</ext-link>), which encodes for a sulfotransferase
involved in the biosynthesis of A47934 from <italic>Streptomyces
toyocaensis</italic> NRRL 15009.<sup><xref ref-type="bibr" rid="ref35">35</xref></sup> Additionally, the WAC 01424 BGC-encoded halogenases seem more related
to the ones from the A47934 BGC than to Noc24 and Dbv8 (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschembio.1c00170/suppl_file/cb1c00170_si_001.pdf">Figure S7</ext-link>). Thus, we suggest that WAC 01424 GPA
is a nonmannosylated, but sulfated, A40926 analogue, putatively with
a halogenation pattern different from A40926 (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschembio.1c00170/suppl_file/cb1c00170_si_001.pdf">Figure S8</ext-link>).</p></sec><sec id="sec2.4"><label>2.4</label><title>Optimization of GPA-Producing
Conditions for <italic>N. coxensis</italic></title><p><italic>N. coxensis</italic> was first described in
2007,<sup><xref ref-type="bibr" rid="ref36">36</xref></sup> but as
far as we know, it was never tested for the production of antimicrobials.
Considering the predicted similarity between the putative GPA produced
by <italic>N. coxensis</italic> with A40926, we first
applied to <italic>N. coxensis</italic> the cultivation
and A40926 production conditions that we had previously optimized
for <italic>N. gerenzanensis</italic>.<sup><xref ref-type="bibr" rid="ref22">22</xref>,<xref ref-type="bibr" rid="ref37">37</xref></sup> In these conditions (namely a vegetative preculture in E26 medium
and a GPA production step in FM2 medium using baffled flasks), <italic>N. coxensis</italic> tended to grow poorly, and no antimicrobial
activity was detectable throughout the 168h cultivation from inoculum.
Thus, we further screened different media and fermentation conditions
previously used for growing other GPA producing strains, such as TM1
used for teicoplanin production by <italic>A. teichomyceticus</italic>(<xref ref-type="bibr" rid="ref38">38</xref>) and R5 adopted for balhimycin production
in <italic>Amycolatopsis balhimycina</italic>,<sup><xref ref-type="bibr" rid="ref39">39</xref></sup> as well as VM0.1 and ISP2l previously employed
for the vegetative cultivation of <italic>N. coxensis</italic>(<xref ref-type="bibr" rid="ref6">6</xref>) (media composition detailed in the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschembio.1c00170/suppl_file/cb1c00170_si_001.pdf">Supporting Information</ext-link>). The production of antimicrobial
activity toward <italic>Bacillus subtilis</italic> ATCC
6633 was observed only in TM1 and ISP2l media when glass beads were
added to favor dispersed growth (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschembio.1c00170/suppl_file/cb1c00170_si_001.pdf">Figure S9</ext-link>). Indeed, adding glass beads to E26 medium cultures allowed us to
use it for a successful vegetative preculture step (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschembio.1c00170/suppl_file/cb1c00170_si_001.pdf">Figure S10A</ext-link>). Interestingly, routine analysis of glucose consumption
in all media described above indicated that <italic>N. coxensis</italic> did not visibly consume glucose during growth (data not shown).
We thus tested the glucose-lacking E26 (named E27), TM1 (TM1m), and
ISP2l (ISP2lm) media variants for <italic>N. coxensis</italic> growth and putative GPA production. We found that biomass accumulation
was similar in E26 and E27 (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschembio.1c00170/suppl_file/cb1c00170_si_001.pdf">Figure S10A</ext-link>) and that biomass and antimicrobial production were equivalent in
TM1 and ISP2l as well as in their glucose lacking variants TM1m and
ISP2lm (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschembio.1c00170/suppl_file/cb1c00170_si_001.pdf">Figure S10B and C</ext-link>). Currently,
it is impossible to say why <italic>N. coxensis</italic> fails to use glucose throughout cultivation given that all necessary
genes are present within its genome (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschembio.1c00170/suppl_file/cb1c00170_si_001.pdf">Figure S10D</ext-link>). Thus, for all the following work with <italic>N. coxensis</italic>, E27, TM1m, and ISP2lm were used.</p></sec><sec id="sec2.5"><label>2.5</label><title>Expression
of VanY-like Activity in <italic>N. coxensis</italic></title><p>As already mentioned, the <italic>noc</italic> BGC encodes
a Dbv7 orthologue&#x02014;Noc27. We therefore
tested whether <sc>d</sc>,<sc>d</sc>-carboxypeptidase activity could
be detected in GPA-producing cultures of <italic>N. coxensis</italic>. This was measured in membrane extracts as previously reported for <italic>N. gerenzanensis</italic> and its mutant strains.<sup><xref ref-type="bibr" rid="ref22">22</xref></sup><sc>d</sc>,<sc>d</sc>-carboxypeptidase activity
was measurable in <italic>N. coxensis</italic> extracts,
although at an inferior level than in <italic>N. gerenzanensis</italic> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschembio.1c00170/suppl_file/cb1c00170_si_001.pdf">Figure S11</ext-link>). This indicated that Noc27
is functional and its expression correlates with the antimicrobial
producing conditions. These results corroborate the hypothesis that <italic>noc</italic> genes are expressed and a novel GPA active versus <italic>B. subtilis</italic> is produced by <italic>N. coxensis.</italic> As in <italic>dbv</italic>(<xref ref-type="bibr" rid="ref40">40</xref>) and WAC
01424 BGCs, a <italic>vanY</italic> gene seems to be the only cluster-situated
determinant of self-resistance in <italic>N. coxensis</italic>.</p></sec><sec id="sec2.6"><label>2.6</label><title>Purification and Identification of the Novel
Glycopeptide Complex Produced by <italic>N. coxensis</italic></title><p><sc>d</sc>-Alanine-<sc>d</sc>-Alanine (<sc>d</sc>-Ala-<sc>d</sc>-Ala) affinity resin chromatography was used to capture the
putative GPA from cultures of <italic>N. coxensis</italic> grown in ISP2lm and TM1m media. ISP2lm appeared to be the most suitable
medium for GPA purification, since the rich composition and high viscosity
of TM1m interfered with affinity chromatography. Analyzed by HPLC,
the affinity resin eluates contained two major peaks with the characteristic
UV spectra of the commercially available A40926 standard, but with
a different retention time (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschembio.1c00170/suppl_file/cb1c00170_si_001.pdf">Figure S12</ext-link>).
LC-MS analysis of these peaks revealed they corresponded to ions with <italic>m</italic>/<italic>z</italic> 852.3 and 859.3 ([M + 2H]<sup>2+</sup>), 28 and 14 Da smaller respectively than an A40926 standard ([M
+ 2H]<sup>2+</sup> = 866.3, corresponding to A40926 B). We therefore
tentatively named this new GPA complex A50926 (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>a and c).</p><fig id="fig4" position="float"><label>Figure 4</label><caption><p>MS characterization of novel GPA complex
produced by wild type <italic>N. coxensis</italic> grown
in ISP2lm and TM1m media for 7
days. (a) Extracted ion chromatograms (EICs) of masses corresponding
to A40926 B (left column) and the major components of the A50926 complex
produced by <italic>N. coxensis</italic> WT, A50926
B (<italic>m</italic>/<italic>z</italic> 859.3, second column), and
A50926 A (<italic>m</italic>/<italic>z</italic> 852.3, third column).
The top row corresponds to a commercial standard of A40926 and the
middle and bottom rows to culture extracts from ISP2lm and TM1m, respectively.
For each mass, peak heights are normalized relative to the intensity
of the largest peak in the sample set, shown in brackets at the top
of each column. (b) MS spectra for A40926 B, A50926 B, and A50926
A. Peak heights are normalized to the intensity of the top peak in
each spectrum, shown on the top right corner of each plot. Signature
in-source fragments for each of the analyzed molecules are circled
in pink, blue, and green, respectively, whereas the fragment corresponding
to the mannosylated aglycone common to all of them is highlighted
in yellow. (c) Proposed structure for the A50926 molecules. The top
schematic represents a generic proposed structure common to A40926
and A50926 while the insets below represent the differential fragments
for each of the analyzed molecules, as inferred from MS and MS/MS
data.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cb1c00170_0003" id="gr4" position="float"/></fig><p>All three molecules showed similar
MS spectra with single, double,
and triple charge proton adducts as well as in-source fragments corresponding
to the aglycone carrying the mannose moiety and the Glc<italic>N</italic>-Acyl moiety (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>b,c). The mannosylated aglycone fragment (<italic>m</italic>/<italic>z</italic> 1374.3) was common to all three peaks (<xref rid="fig4" ref-type="fig">Figures <xref rid="fig4" ref-type="fig">4</xref></xref>b and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschembio.1c00170/suppl_file/cb1c00170_si_001.pdf">S13</ext-link>), indicating that they share the same aglycone structure
and mannose decoration. In contrast, the in-source fragment corresponding
to the acylated sugar carried the signature mass difference for each
molecule (<xref rid="fig4" ref-type="fig">Figures <xref rid="fig4" ref-type="fig">4</xref></xref>b, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschembio.1c00170/suppl_file/cb1c00170_si_001.pdf">S14, and S15</ext-link>): the main A50926 peak
([M + H]<sup>+</sup> = 1717.5361) had a fragment with <italic>m</italic>/<italic>z</italic> 344.2, whereas the A40926 standard had a fragment
with <italic>m</italic>/<italic>z</italic> 358.22 (<xref rid="fig4" ref-type="fig">Figures <xref rid="fig4" ref-type="fig">4</xref></xref>b, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschembio.1c00170/suppl_file/cb1c00170_si_001.pdf">S14, and S15</ext-link>). Further MS and MS/MS analyses of these fragments
(<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschembio.1c00170/suppl_file/cb1c00170_si_001.pdf">Figures S14 and S16</ext-link>) allowed us to assign
this 14 Da mass difference to the glucosamine moiety. The masses are
consistent with this sugar featuring a regular 6-hydroxyl group in
A50926 versus being carboxylated in A40926 (<xref rid="fig1" ref-type="fig">Figures <xref rid="fig1" ref-type="fig">1</xref></xref>, <xref rid="fig3" ref-type="fig">3</xref>, <xref rid="fig4" ref-type="fig">4</xref>c, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschembio.1c00170/suppl_file/cb1c00170_si_001.pdf">S14, S15, and S16</ext-link>). This correlates
with the lack of a homologue of <italic>dbv29</italic> in the <italic>noc</italic> BGC, as it encodes the enzyme responsible for the oxidation
of the C-6 hydroxyl group of Glc<italic>N</italic>-Acyl into a carboxylic
acid in A40926. The second A50926 peak ([M + H]<sup>+</sup> = 1703.5172)
had a further 14 Da mass difference in the Glc<italic>N</italic>-Acyl
moiety (<xref rid="fig4" ref-type="fig">Figures <xref rid="fig4" ref-type="fig">4</xref></xref>b
and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschembio.1c00170/suppl_file/cb1c00170_si_001.pdf">S14</ext-link>), but in this case MS/MS showed
this difference to be in the acyl chain (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschembio.1c00170/suppl_file/cb1c00170_si_001.pdf">Figure S16</ext-link>), which is consistent with an A50926 congener with a C11
acyl chain instead of a C12 acyl chain. This is equivalent to the
A and B series of congeners in the A40926 complex.<sup><xref ref-type="bibr" rid="ref41">41</xref></sup> Based on this analysis and accurate mass data (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>b), we named the
compound with [M + H]<sup>+</sup> = 1717.54 A50926 B (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>c) and the compound with [M
+ H]<sup>+</sup> = 1703.52 A50926 A (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>c).</p></sec><sec id="sec2.7"><label>2.7</label><title>Single Gene Expression
Leads to A40926 Production
in <italic>N. coxensis</italic></title><p>To support
our MS-based characterization of A50926, we hypothesized that we could
convert <italic>N. coxensis</italic> into an A40926
producer by overexpression of the <italic>dbv29</italic> gene from <italic>N. gerenzanensis</italic>, which encodes the hexose oxidase
required for oxidation of the C-6 hydroxyl group of Glc<italic>N</italic>-Acyl into the corresponding carboxylic acid. To achieve this, we
used the pSET152A expression platform, which has proven to be very
effective for gene overexpression in both <italic>N. coxensis</italic> and <italic>N. gerenzanensis</italic>.<sup><xref ref-type="bibr" rid="ref6">6</xref></sup><italic>dbv29</italic> was cloned into pSET152A to generate
pSAD29, which was then introduced into <italic>N. coxensis</italic> by conjugation from <italic>Escherichia coli</italic>. <italic>N. coxensis</italic> pSAD29<sup>+</sup> was
grown in ISP2lm medium for 168 h, and the resulting GPA complex was
purified using <sc>d</sc>-Ala-<sc>d</sc>-Ala affinity resin. LC-MS
analysis determined that <italic>N. coxensis</italic> pSAD29<sup>+</sup> was able to produce a molecule with an identical
retention time and MS spectrum to that of A40926 (observed <italic>m</italic>/<italic>z</italic> 1731.5181, calculated A40926 [M + H]<sup>+</sup> 1731.5107, 4.27 ppm difference) (<xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>a and b).</p><fig id="fig5" position="float"><label>Figure 5</label><caption><p>Production of A40926 in <italic>N. coxensis</italic> pSAD29<sup>+</sup> grown in ISP2lm for
7 days. (a) EICs for masses
corresponding to A40926 B (red trace), A50926 B (purple), and A50926
A (green) in purified extracts of <italic>N. coxensis</italic> pSAD29<sup>+</sup> (top chromatogram) and <italic>N. coxensis</italic> WT (middle) in comparison to an A40926 commercial standard. The
intensity for the top peak in each chromatogram is shown in brackets
under the sample name. (b) MS spectrum of A40926 B from <italic>N. coxensis</italic> pSAD29<sup>+</sup> cultures. Monoisotopic
masses corresponding to [M + 2H]<sup>2+</sup> and [M + H]<sup>+</sup> adducts are highlighted in red, and the deviation between the observed
accurate mass and the predicted mass for A40926 is represented in
parts per million. (c) MS/MS spectra of A40926 B produced by <italic>N. coxensis</italic> pSAD29<sup>+</sup> and an A40926 B commercial
standard.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cb1c00170_0004" id="gr5" position="float"/></fig><p>MS/MS analysis of the molecule
showed it also had an identical
fragmentation pattern to the A40926 standard, including the in-source
fragment with <italic>m</italic>/<italic>z</italic> 358.22 characteristic
of the carboxylated Glc<italic>N</italic>-Acyl moiety (<xref rid="fig5" ref-type="fig">Figures <xref rid="fig5" ref-type="fig">5</xref></xref>c and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschembio.1c00170/suppl_file/cb1c00170_si_001.pdf">S17</ext-link>). Traces of A50926 could also be detected in the extract
of the complemented strain, indicating that while complementation
was very efficient, conversion from A50926 to A40926 was not complete
(<xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>a). Alongside
the BGC homology (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>), this provides strong evidence that A50926 is chemically
identical to A40926 with the exception of the carboxylated Glc<italic>N</italic>-Acyl. However, we cannot completely rule out small differences,
such as acyl chain branching.</p></sec><sec id="sec2.8"><label>2.8</label><title>Heterologous
Expression of Transcriptional
Regulators <italic>dbv3</italic> and <italic>dbv4</italic> to Enhance
the Production of A50926 in <italic>N. coxensis</italic></title><p>In previous work, we overexpressed the two <italic>dbv</italic> BGC situated master regulators in <italic>N. gerenzanensis</italic> (<italic>dbv4</italic> and <italic>dbv3</italic>) to successfully
improve A40926 production.<sup><xref ref-type="bibr" rid="ref6">6</xref></sup> Therefore,
hereby we used the previously constructed expression vectors pSAD4
and pSAD3 carrying <italic>dbv4</italic> and <italic>dbv3</italic>, respectively, in <italic>N. coxensis</italic> to
trigger and improve A50926 production. First, we observed that <italic>N. coxensis</italic> pSAD3<sup>+</sup> and pSAD4<sup>+</sup> recombinant strains grown in the E27 and VSP vegetative media produced
an antimicrobial activity against <italic>B. subtilis</italic> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschembio.1c00170/suppl_file/cb1c00170_si_001.pdf">Figure S18A</ext-link>), whereas their parental
wild type strain did not exhibit any antimicrobial activity in these
media. Overexpression of <italic>dbv3</italic> also triggered antimicrobial
activity on VM0.1 and ISP2 solid media, whereas the wild type was
not active (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschembio.1c00170/suppl_file/cb1c00170_si_001.pdf">Figure S18B</ext-link>). Consistently,
in both ISP2lm and TM1m production media <italic>N. coxensis</italic> pSAD3<sup>+</sup> and pSAD4<sup>+</sup> produced more antibiotic
than the wild type (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschembio.1c00170/suppl_file/cb1c00170_si_001.pdf">Figures S18C</ext-link> and <xref rid="fig6" ref-type="fig">6</xref>a and b). In ISP2lm (<xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>a), at 192 h <italic>N. coxensis</italic> pSAD3<sup>+</sup> reached the maximum production of approximately
45 &#x003bc;g mL<sup>&#x02013;1</sup>, exceeding both wild type (approximately
20 &#x003bc;g mL<sup>&#x02013;1</sup>) and <italic>N. coxensis</italic> pSAD4<sup>+</sup> (approximately 30 &#x003bc;g mL<sup>&#x02013;1</sup>) productivities. In TM1m medium (<xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>b), <italic>N. coxensis</italic> pSAD3<sup>+</sup> produced approximately 50 &#x003bc;g mL<sup>&#x02013;1</sup> after 192 h of cultivation. At the same time point in TM1m the wild
type and <italic>N. coxensis</italic> pSAD4<sup>+</sup> produced approximately 16 and 22 &#x003bc;g mL<sup>&#x02013;1</sup> of antibiotic, respectively. The control strain carrying the &#x0201c;empty&#x0201d;
pSET152A vector performed exactly as the wild type (data not shown).
No significant differences between biomass accumulation or pH were
observed among the recombinant strains, or in comparison with the
parental <italic>N. coxensis</italic> wild type strain.
Thus, overexpression of <italic>dbv3</italic> and <italic>dbv4</italic> regulatory genes triggered or improved the production of A50926
in <italic>N. coxensis</italic> under different cultivation
conditions.</p><fig id="fig6" position="float"><label>Figure 6</label><caption><p>Time courses of <italic>N. coxensis</italic> wild
type and of the recombinant strains overexpressing <italic>dbv3</italic> (pSAD3<sup>+</sup>) and <italic>dbv4</italic> (pSAD4<sup>+</sup>) cultivated in ISP2lm (a) or TM1m (b) in 500 mL Erlenmeyer flasks.
pH (filled circles), biomass accumulation (empty squares), and A50926
production were monitored every 24 h. Results given are mean values
of three independent experiments, and error bars represent standard
deviations.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cb1c00170_0005" id="gr6" position="float"/></fig></sec></sec><sec id="sec3"><label>3</label><title>Conclusions</title><p>A novel GPA, A50926, was identified from <italic>N. coxensis</italic> DSM 45129. Detailed MS and MS/MS analysis indicates that A50926
differs from the previously characterized A40926 GPA by lacking the
carboxyl group on the Glc<italic>N</italic>-Acyl moiety attached to
Hpg4 of the GPA aglycone, resembling teicoplanin in this part of the
molecule. A compound with the same chemical structure was described
25 years ago as a chemically prepared derivative of A40926 (named
RA<sup><xref ref-type="bibr" rid="ref28">28</xref></sup>). Extensive study of antibacterial
activities of RA <italic>in vitro</italic>(<xref ref-type="bibr" rid="ref28">28</xref>) indicated that RA has slightly better antimicrobial activity than
A40926: minimal inhibitory concentrations (MICs) of RA were 2&#x02013;4
times lower against different staphylococcal and enterococcal strains
when compared to A40926. The difference of chemical structure between
the newly described A50926 and A40926 correlates with the absence
of <italic>dbv29</italic> orthologue in the A50926 BGC (<italic>noc</italic>). Consistently, when <italic>dbv29</italic> was introduced into <italic>N. coxensis</italic>, we obtained A40926 production in the
recombinant strain. Otherwise, both <italic>noc</italic> and <italic>dbv</italic> BGCs share all biosynthetic genes, which are closely
related. Heterologous expression of A40926 regulatory genes <italic>dbv3</italic> and <italic>dbv4</italic> in <italic>N. coxensis</italic> improved A50926 production.</p><p>Although the majority of <italic>noc</italic> and <italic>dbv</italic> genes are orthologous, the <italic>dbv</italic> BGC is significantly
rearranged in comparison to the <italic>noc</italic> BGC, as well
as all other characterized GPA BGCs. We have proposed a series of
genetic inversions that could have occurred in a common <italic>Nonomuraea</italic> ancestor to explain these different genetic
architectures. Both BGCs are quite similar to the putative GPA BGC
from <italic>Nonomuraea</italic> sp. WAC 01424. The
latter lacks genes required for the addition of mannose, but possesses
a gene encoding a sulfotransferase and an additional gene encoding
a halogenase. Thus, the putative nonmannosylated GPA from <italic>Nonomuraea</italic> sp. WAC 01424 might be sulfated and have
a different chlorination pattern than A40926/A50926. Consequently, <italic>Nonomuraea</italic> sp. WAC 01424 GPA BGC seems an attractive
source for new tailoring genes to obtain A40926 derivatives with altered
pharmacological properties. Notwithstanding the GPA BGC similarity,
multilocus phylogeny of <italic>Nonomuraea</italic> spp.
shows that GPA producers are not clustered together: GPA producers
are found in distinct clades within the genus. Our analysis indicates
that type IV and V GPA BGCs are common in <italic>Nonomuraea</italic> spp., which is in contrast to how rare these BGCs were believed
to be. This is comparable to studies that show that BGCs for types
I&#x02013;III&#x02013;IV GPAs are common in <italic>Amycolatopsis</italic>, and type V GPAs in <italic>Streptomyces.</italic>(<xref ref-type="bibr" rid="ref27">27</xref>,<xref ref-type="bibr" rid="ref42">42</xref>,<xref ref-type="bibr" rid="ref43">43</xref>) This highlights how
rare actinomycete genera, such as <italic>Nonomuraea</italic>, may represent a rich untapped source of novel GPAs, as well as
GPA tailoring enzymes for the diversification of existing GPA scaffolds.</p></sec><sec id="sec4"><label>4</label><title>Methods</title><sec id="sec4.1"><label>4.1</label><title>Bacterial Strains and Cultivation Conditions</title><p>Bacterial
strains and plasmids used in this work are summarized
in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschembio.1c00170/suppl_file/cb1c00170_si_001.pdf">Table S6</ext-link>. Compositions of all the media
used for cultivation and GPA production are also given in the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschembio.1c00170/suppl_file/cb1c00170_si_001.pdf">Supporting Information</ext-link>. All media components
and antibiotics were supplied by Sigma-Aldrich, unless otherwise stated.
For routine maintenance, <italic>N. gerenzanensis</italic> and <italic>N. coxensis</italic> strains were cultivated
on ISP3 agar medium supplemented with 50 &#x003bc;g mL<sup>&#x02013;1</sup> apramycin-sulfate when appropriate. For genomic DNA isolation, <italic>N. gerenzanensis</italic> and <italic>N. coxensis</italic> strains were cultivated in liquid VSP medium on an orbital shaker
at 220 rpm and at 30 &#x000b0;C. The working cell banks (WCBs) for <italic>N. gerenzanensis</italic> and <italic>N. coxensis</italic> strains were prepared as described previously.<sup><xref ref-type="bibr" rid="ref22">22</xref>,<xref ref-type="bibr" rid="ref37">37</xref></sup><italic>E. coli</italic> DH5&#x003b1; was used as a routine cloning
host, and <italic>E. coli</italic> ET12567 pUZ8002 was used as a donor
for intergeneric conjugations. <italic>E. coli</italic> strains were cultivated at 37 &#x000b0;C in LB liquid or agar media
supplemented with 100 &#x003bc;g mL<sup>&#x02013;1</sup> of apramycin-sulfate,
50 &#x003bc;g mL<sup>&#x02013;1</sup> of kanamycin-sulfate, and 25 &#x003bc;g
mL<sup>&#x02013;1</sup> of chloramphenicol when appropriate.</p></sec><sec id="sec4.2"><label>4.2</label><title>Plasmid Construction and Generation of Recombinant <italic>N. coxensis</italic> Strains</title><p>To construct the pSAD29
expression vector, the coding sequence of <italic>dbv29</italic> (1601
bp) was amplified from the genomic DNA of <italic>N. gerenzanensis</italic> using dbv29_F/R primer pair (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschembio.1c00170/suppl_file/cb1c00170_si_001.pdf">Table S7</ext-link>) and Q5 high-fidelity DNA polymerase (New England Biolabs). The
resulting amplicon was digested with <italic>Eco</italic>RI and <italic>Eco</italic>RV restriction endonucleases and cloned into pSET152A<sup><xref ref-type="bibr" rid="ref44">44</xref>,<xref ref-type="bibr" rid="ref45">45</xref></sup> cleaved at the same binding sites. The resulting plasmid was verified
by endonuclease restriction mapping and sequencing at BMR Genomics.</p><p>pSAD29, as well as pSAD3,<sup><xref ref-type="bibr" rid="ref6">6</xref></sup> pSAD4,<sup><xref ref-type="bibr" rid="ref6">6</xref></sup> and pSET152A,<sup><xref ref-type="bibr" rid="ref44">44</xref></sup> were
transferred to <italic>N. coxensis</italic> conjugatively,
as described previously.<sup><xref ref-type="bibr" rid="ref6">6</xref></sup> Transconjugants
were selected as resistant to 50 &#x003bc;g mL<sup>&#x02013;1</sup> of
apramycin-sulfate. Obtained strains were verified by PCR. To verify
the integration of pSAD29, a &#x0223c;1.1 kbp fragment of pSAD29 was
amplified using the dbv29_seq_int/PAM_seq_R (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschembio.1c00170/suppl_file/cb1c00170_si_001.pdf">Table S7</ext-link>) primer pair, in which dbv29_seq_int anneals within <italic>dbv29</italic> and PAM_seq_R anneals upstream the <italic>Eco</italic>RV cleavage site of pSET152A. To verify the integrations of pSAD4
and pSAD3, &#x0223c;1 kbp and &#x0223c;2 kbp fragments were amplified
respectively using PAM_seq_F/dbv4_R and PAM_seq_F/dbv3_seq_R primer
pairs (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschembio.1c00170/suppl_file/cb1c00170_si_001.pdf">Table S7</ext-link>). Finally, the integration
of pSET152A was verified by amplifying <italic>aac(3)IV</italic> with
the aac(3)IV_F/R primer pair (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschembio.1c00170/suppl_file/cb1c00170_si_001.pdf">Table S7</ext-link>).
In all cases, genomic DNA was isolated using the Kirby procedure.<sup><xref ref-type="bibr" rid="ref46">46</xref></sup></p></sec><sec id="sec4.3"><label>4.3</label><title><italic>N. coxensis</italic> Cultivation for A50926 Production</title><p>To initiate the cultivation
of <italic>N. coxensis</italic>, one WCB vial was inoculated
into a 250 mL Erlenmeyer flask with 50 mL of VSP reactivation medium
containing 6 glass beads (&#x000f8;5 mm). After 72 h of incubation on
a rotary shaker at 220 rpm, 30 &#x000b0;C the culture was used to inoculate
(10% v/v) 500 mL Erlenmeyer flasks containing 100 mL of E27 vegetative
medium and 12 glass beads (&#x02300; 5 mm). Following 72 h of incubation
on a rotary shaker at 220 rpm, 30 &#x000b0;C this culture was used to
inoculate (10% v/v) 500 mL Erlenmeyer flasks with 100 mL of ISP2lm
or TM1m production media containing 12 glass beads (&#x02300; 5 mm).
A50926 production cultures were then incubated up to 240 h on a rotary
shaker at 220 rpm, 30 &#x000b0;C. Samples were collected at regular time
points to estimate biomass accumulation (dry weight), pH, and A50926
production.</p></sec><sec id="sec4.4"><label>4.4</label><title>VanY-Related Activity Measurement</title><p><sc>d</sc>,<sc>d</sc>-carboxypeptidase activity in <italic>Nonomuraea</italic> spp. was measured in FM2 production medium
(<italic>N. gerenzanensis</italic>) and ISP2lm (<italic>N. coxensis</italic>) at 24, 48, 72, 96, 120, and 144 h time
points. Mycelial lysates were prepared as described previously.<sup><xref ref-type="bibr" rid="ref34">34</xref></sup> The enzyme activity releasing <sc>d</sc>-Ala
from the tripeptide <italic>N</italic>-Acetyl-<sc>l</sc>-Lys-<sc>d</sc>-Ala-<sc>d</sc>-Ala (10 mM) was followed spectrophotometrically by
a <sc>d</sc>-amino acid oxidase/peroxidase coupled reaction that oxidizes
the colorimetric substrate 4-aminoantipyrine to chinonemine. <sc>d</sc>,<sc>d</sc>-carboxypeptidase activity was normalized to dry biomass
weight, as previously reported.<sup><xref ref-type="bibr" rid="ref22">22</xref></sup> One unit
is defined as the amount of enzyme that is able to convert 1 &#x003bc;mol
of substrate in 1 min.</p></sec><sec id="sec4.5"><label>4.5</label><title>HPLC and LC-MS Analysis
of GPAs</title><p>For
quantitative measurement, A40926 and A50926 were extracted from <italic>N. coxensis</italic> cultures with equal volumes of borate
buffer composed of 100 mM H<sub>3</sub>BO<sub>3</sub> (Sigma-Aldrich)
and 100 mM NaOH (Sigma-Aldrich), pH 12. During this extraction the <italic>O-</italic>acetylated forms were converted in the corresponding deacetylated
GPAs A40926 and A50926. A40926 and A50926 were analyzed using HPLC
as previously reported.<sup><xref ref-type="bibr" rid="ref6">6</xref>,<xref ref-type="bibr" rid="ref22">22</xref>,<xref ref-type="bibr" rid="ref37">37</xref></sup> In all cases the injection volumes of studied samples and standards
were the same (50 &#x003bc;L). Concentration of A50926 was estimated
as follows:<disp-formula id="eq1"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cb1c00170_m001" position="anchor"/></disp-formula>Where, <italic>C</italic>(A40926
std) is the
concentration of the commercial A40926 sample; <italic>A</italic>(A50926)
is the area sum of the peaks corresponding to A50926 B; <italic>A</italic>(A40926 std) is the area of the peak corresponding to the standard
A40926 factor B<sub>0</sub>; and 2 is the dilution factor.</p><p>High
resolution liquid chromatography&#x02013;mass spectrometry (LC-MS)
and fragmentation (MS/MS) analysis of A40926 and A50926 was carried
out on a SYNAPT G2-Si mass spectrometer equipped with an Acquity UPLC
(Waters). Samples were injected onto a Waters Acquity UPLC BEH 1.7
&#x003bc;m, 1 &#x000d7; 100 mm C18 column, and eluted with a gradient of
(B) acetonitrile/0.1% formic acid in (A) water/0.1% formic acid with
a flow rate of 0.08 mL min<sup>&#x02013;1</sup> at 45 &#x000b0;C. The
concentration of B was kept at 1% for 2 min followed by a gradient
up to 40% B over 9 min, ramping to 99% B in 1 min, kept at 99% B for
2 min and re-equilibrated at 1% B for 4 min. MS data were collected
in positive mode with the following parameters: resolution mode, scan
time 0.5 s, mass range <italic>m</italic>/<italic>z</italic> 50&#x02013;2000
calibrated with sodium iodide, capillary voltage = 2.5 kV; cone voltage
= 40 V; source temperature = 120 &#x000b0;C; desolvation temperature
= 350 &#x000b0;C. Leu-enkephalin peptide was used to generate a lock-mass
calibration with <italic>m</italic>/<italic>z</italic> 556.2766 for
positive mode, measured every 90 s during the run. For MS/MS fragmentation,
a data directed analysis (DDA) method was used with the following
parameters: precursor selected from the 4 most intense ions; MS/MS
threshold 5000; scan time 2 s; no dynamic exclusion. Collision energy
(CE) was ramped between 8 and 35 at low mass (<italic>m</italic>/<italic>z</italic> 50) and 10&#x02013;70 at high mass (<italic>m</italic>/<italic>z</italic> 1200).</p></sec><sec id="sec4.6"><label>4.6</label><title>Purification of GPAs Using <sc>d</sc>-Ala-<sc>d</sc>-Ala Based Affinity Resin</title><p>GPAs were
purified by affinity
chromatography with a <sc>d</sc>-Alanine-<sc>d</sc>-Alanine (<sc>d</sc>-Ala-<sc>d</sc>-Ala) based resin. Activation of 5 mL HiTrap NHS-activated
HP affinity columns (GE Healthcare) and ligand binding was conducted
as described before<sup><xref ref-type="bibr" rid="ref47">47</xref></sup> with modifications.
Briefly, the resin was activated with 30 mL of 1 mM HCl, followed
by injection of 200 mM <sc>d</sc>-Ala-<sc>d</sc>-Ala dipeptide, dissolved
into 5 mL of coupling buffer (0.2 M NaHCO<sub>3</sub>, pH 7.0). After
30 min incubation, the resin was washed with three cycles of 0.5 M
ethanolamine hydrochloride, 0.5 M NaCl (pH 4.0, 30 mL), followed by
0.1 M sodium acetate, 0.5 mM NaCl (pH 4.0, 30 mL), alternately. Finally,
the resin was washed with 50 mL coupling buffer and left to equilibrate
for at least 1 h before use.</p><p><italic>N. coxensis</italic> cultures were extracted in borate buffer as reported above, the
pH in the obtained extracts was adjusted to 7.5 with HCl, and they
were applied to the affinity chromatography system. Thus, extracts
in borate buffer, coming from <italic>N. coxensis</italic> strains cultivated in TM1m or ISP2lm media, were filtered with 0.45
&#x003bc;m cutoff and loaded onto a <sc>d</sc>-Ala-<sc>d</sc>-Ala column
at a flow rate of 0.5 mL min<sup>&#x02013;1</sup>. After extensive
washing with coupling buffer, the bound GPA was eluted with 0.1 M
NaOH and the eluate was lyophilized.</p></sec><sec id="sec4.7"><label>4.7</label><title>Bioassays
for the Detection of A50926</title><p>Agar plug or Whatman paper disc
(GE Healthcare) antibiotic diffusion
assays were used to determine antimicrobial activities. An overnight <italic>B. subtilis</italic> ATCC 6633 culture in Mueller-Hinton broth
II (cation adjusted, Sigma-Aldrich) was used to inoculate (1% v/v)
a fresh culture, which was grown to OD<sub>600</sub> = 0.6. A 200
&#x003bc;L portion of this culture was then added to 25 mL of 0.7% (w/v
) Mueller-Hinton agar (Condalab) and plated. After solidification
of the media, agar plugs cut from the plates with <italic>N.
coxensis</italic> lawns, or Whatman paper discs containing
GPAs, were placed on the agar surface. Bioassay plates were incubated
for 16 h at 37 &#x000b0;C before examination.</p></sec><sec id="sec4.8"><label>4.8</label><title>Sequencing
and Annotation of the <italic>N. coxensis</italic> Genome</title><p>The genome of <italic>N. coxensis</italic> was sequenced
using a combination of
HiSeq Illumina and GridION ONT technologies. The Illumina data was
obtained from SRA (PRJNA165411), while for the ONT data, a sequencing
library (SQK-LSK109) was prepared using the Ligation Sequencing Kit
(Oxford Nanopore Technologies) according to the manufacturer&#x02019;s
instructions and run on a GridION sequencer in an R9.4.1 flowcell
(both Oxford Nanopore Technologies). Base-calling of the raw data
was performed with GUPPY-FOR-GRIDION v3.0.6. The assembly and polishing
were performed as described previously,<sup><xref ref-type="bibr" rid="ref48">48</xref></sup> using canu v.1.8 instead of v.1.6. The ONT data was assembled into
5 contigs, while the Illumina data were assembled into 87 scaffolds
containing 310 contigs using NEWBLER v2.8. After manual curation using
CONSED,<sup><xref ref-type="bibr" rid="ref49">49</xref></sup> the complete genome of <italic>N. coxensis</italic> DSM 45129, consisting of one circular
chromosome of 9,073,954 bp (72.12% G + C) was obtained. Annotation
was performed using PROKKA v1.11<sup><xref ref-type="bibr" rid="ref50">50</xref></sup> resulting
in the prediction of 8,398 coding sequences (CDS), 5 rRNA operons,
73 tRNAs, and 5 noncoding RNA elements. The annotated genome and ONT
raw data were deposited at DDBJ/ENA/GenBank under the BioProject accession
number PRJNA693185.</p></sec><sec id="sec4.9"><label>4.9</label><title><italic>In Silico</italic> Analysis Tools
and Approaches</title><p>Routine analysis of nucleotide and amino acid
sequences was performed in GENEIOUS v4.8.5.<sup><xref ref-type="bibr" rid="ref51">51</xref></sup> Multiple sequence alignments, selection of the best models for the
phylogenetic reconstruction and phylogenetic reconstruction itself
were done with the MEGA X package.<sup><xref ref-type="bibr" rid="ref52">52</xref></sup> To
reconstruct the multilocus phylogeny of <italic>Nonomuraea</italic>, orthologues of 30 <italic>S. coelicolor</italic> house-keeping
proteins (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschembio.1c00170/suppl_file/cb1c00170_si_001.pdf">Table S3</ext-link>,<sup><xref ref-type="bibr" rid="ref53">53</xref></sup>) were identified within the genomes of 34 <italic>Nonomuraea</italic> spp. (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschembio.1c00170/suppl_file/cb1c00170_si_001.pdf">Table S2</ext-link>) using reciprocal best hit (RBH) BLAST. Sequences of these proteins
from each <italic>Nonomuraea</italic> spp. were concatenated,
and these concatenates were used for the upstream phylogenetic reconstruction.</p></sec></sec></body><back><notes id="notes1" notes-type="si"><title>Supporting Information Available</title><p>The Supporting Information is
available free of charge at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/10.1021/acschembio.1c00170?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acschembio.1c00170</ext-link>.<list id="silist" list-type="simple"><list-item><p>Tables S1&#x02013;S7 and
Figures S1&#x02013;S18 (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acschembio.1c00170/suppl_file/cb1c00170_si_001.pdf">PDF</ext-link>)</p></list-item></list></p></notes><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="sifile1"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cb1c00170_si_001.pdf"><caption><p>cb1c00170_si_001.pdf</p></caption></media></supplementary-material></sec><notes notes-type="COI-statement" id="notes2"><p>The authors
declare no competing financial interest.</p></notes><ack><title>Acknowledgments</title><p>This work was supported
by the public grant &#x0201c;Fondo
di Ateneo per la Ricerca&#x0201d; 2019 to F.M., by the Biotechnology
and Biological Sciences Research Council MfN Institute Strategic Programme
grant (BBS/E/J/000PR9790) for the John Innes Centre (JIC) and by a
Royal Society University Research Fellowship for A.W.T. A.A.-V. is
a Ph.D. student of the &#x0201c;Life Science and Biotechnology&#x0201d;
course at Universit&#x000e0; degli Studi dell&#x02019;Insubria. We thank
graduate student E. Salvad&#x000e8; of University of Insubria for her
contribution to this research and Consorzio Interuniversitario per
le Biotecnologie for supporting E.B. and F.B. We thank C. de Oliveira
Martins (JIC) for technical support with mass spectrometry.</p></ack><ref-list><title>References</title><ref id="ref1"><mixed-citation publication-type="journal" id="cit1"><name><surname>Sungthong</surname><given-names>R.</given-names></name>; <name><surname>Nakaew</surname><given-names>N.</given-names></name> (<year>2015</year>) <article-title>The genus <italic>Nonomuraea</italic>: a review of
a rare actinomycete taxon for novel metabolites</article-title>. <source>J. Basic Microbiol.</source>
<volume>55</volume>, <fpage>554</fpage>&#x02013;<lpage>565</lpage>. <pub-id pub-id-type="doi">10.1002/jobm.201300691</pub-id>.<pub-id pub-id-type="pmid">24633812</pub-id></mixed-citation></ref><ref id="ref2"><mixed-citation publication-type="journal" id="cit2"><name><surname>Nazari</surname><given-names>B.</given-names></name>; <name><surname>Forneris</surname><given-names>C. C.</given-names></name>; <name><surname>Gibson</surname><given-names>M. I.</given-names></name>; <name><surname>Moon</surname><given-names>K.</given-names></name>; <name><surname>Schramma</surname><given-names>K. R.</given-names></name>; <name><surname>Seyedsayamdost</surname><given-names>M. R.</given-names></name> (<year>2017</year>) <article-title><italic>Nonomuraea</italic> sp. ATCC 55076 harbours
the largest actinomycete chromosome to date and the kistamicin biosynthetic
gene cluster</article-title>. <source>MedChemComm</source>
<volume>8</volume>, <fpage>780</fpage>&#x02013;<lpage>788</lpage>. <pub-id pub-id-type="doi">10.1039/C6MD00637J</pub-id>.<pub-id pub-id-type="pmid">28626548</pub-id></mixed-citation></ref><ref id="ref3"><mixed-citation publication-type="journal" id="cit3"><name><surname>D&#x02019;Argenio</surname><given-names>V.</given-names></name>; <name><surname>Petrillo</surname><given-names>M.</given-names></name>; <name><surname>Pasanisi</surname><given-names>D.</given-names></name>; <name><surname>Pagliarulo</surname><given-names>C.</given-names></name>; <name><surname>Colicchio</surname><given-names>R.</given-names></name>; <name><surname>Tal&#x000e0;</surname><given-names>A.</given-names></name>; <name><surname>De Biase</surname><given-names>M. S.</given-names></name>; <name><surname>Zanfardino</surname><given-names>M.</given-names></name>; <name><surname>Scolamiero</surname><given-names>E.</given-names></name>; <name><surname>Pagliuca</surname><given-names>C.</given-names></name>; <name><surname>Gaballo</surname><given-names>A.</given-names></name>; <name><surname>Cicatiello</surname><given-names>A. G.</given-names></name>; <name><surname>Cantiello</surname><given-names>P.</given-names></name>; <name><surname>Postiglione</surname><given-names>I.</given-names></name>; <name><surname>Naso</surname><given-names>B.</given-names></name>; <name><surname>Boccia</surname><given-names>A.</given-names></name>; <name><surname>Durante</surname><given-names>M.</given-names></name>; <name><surname>Cozzuto</surname><given-names>L.</given-names></name>; <name><surname>Salvatore</surname><given-names>P.</given-names></name>; <name><surname>Paolella</surname><given-names>G.</given-names></name>; <name><surname>Salvatore</surname><given-names>F.</given-names></name>; <name><surname>Alifano</surname><given-names>P.</given-names></name> (<year>2016</year>) <article-title>The complete 12 Mb
genome and transcriptome of <italic>Nonomuraea gerenzanensis</italic> with new insights into its duplicated &#x0201c;magic&#x0201d; RNA
polymerase</article-title>. <source>Sci. Rep.</source>
<volume>6</volume>, <fpage>18</fpage><pub-id pub-id-type="doi">10.1038/s41598-016-0025-0</pub-id>.<pub-id pub-id-type="pmid">28442708</pub-id></mixed-citation></ref><ref id="ref4"><mixed-citation publication-type="journal" id="cit4"><name><surname>Narsing
Rao</surname><given-names>M. P.</given-names></name>; <name><surname>Dong</surname><given-names>Z. Y.</given-names></name>; <name><surname>Jiao</surname><given-names>J. Y.</given-names></name>; <name><surname>Zhou</surname><given-names>Y.</given-names></name>; <name><surname>Zhao</surname><given-names>J.</given-names></name>; <name><surname>Xiao</surname><given-names>M.</given-names></name>; <name><surname>Li</surname><given-names>W. J.</given-names></name> (<year>2020</year>) <article-title>Genome sequence
and comparative analysis of DRQ-2, the type strain of <italic>Nonomuraea
indica</italic></article-title>. <source>Genomics</source>
<volume>112</volume>, <fpage>2842</fpage>&#x02013;<lpage>2844</lpage>. <pub-id pub-id-type="doi">10.1016/j.ygeno.2020.03.023</pub-id>.<pub-id pub-id-type="pmid">32240724</pub-id></mixed-citation></ref><ref id="ref5"><mixed-citation publication-type="journal" id="cit5"><name><surname>Greule</surname><given-names>A.</given-names></name>; <name><surname>Izor&#x000e9;</surname><given-names>T.</given-names></name>; <name><surname>Iftime</surname><given-names>D.</given-names></name>; <name><surname>Tailhades</surname><given-names>J.</given-names></name>; <name><surname>Schoppet</surname><given-names>M.</given-names></name>; <name><surname>Zhao</surname><given-names>Y.</given-names></name>; <name><surname>Peschke</surname><given-names>M.</given-names></name>; <name><surname>Ahmed</surname><given-names>I.</given-names></name>; <name><surname>Kulik</surname><given-names>A.</given-names></name>; <name><surname>Adamek</surname><given-names>M.</given-names></name>; <name><surname>Goode</surname><given-names>R. J. A.</given-names></name>; <name><surname>Schittenhelm</surname><given-names>R. B.</given-names></name>; <name><surname>Kaczmarski</surname><given-names>J. A.</given-names></name>; <name><surname>Jackson</surname><given-names>C. J.</given-names></name>; <name><surname>Ziemert</surname><given-names>N.</given-names></name>; <name><surname>Krenske</surname><given-names>E. H.</given-names></name>; <name><surname>De Voss</surname><given-names>J. J.</given-names></name>; <name><surname>Stegmann</surname><given-names>E.</given-names></name>; <name><surname>Cryle</surname><given-names>M. J.</given-names></name> (<year>2019</year>) <article-title>Kistamicin biosynthesis
reveals the biosynthetic requirements for production of highly crosslinked
glycopeptide antibiotics</article-title>. <source>Nat. Commun.</source>
<volume>10</volume>, <fpage>2613</fpage><pub-id pub-id-type="doi">10.1038/s41467-019-10384-w</pub-id>.<pub-id pub-id-type="pmid">31197182</pub-id></mixed-citation></ref><ref id="ref6"><mixed-citation publication-type="journal" id="cit6"><name><surname>Yushchuk</surname><given-names>O.</given-names></name>; <name><surname>Andreo-Vidal</surname><given-names>A.</given-names></name>; <name><surname>Marcone</surname><given-names>G. L.</given-names></name>; <name><surname>Bibb</surname><given-names>M.</given-names></name>; <name><surname>Marinelli</surname><given-names>F.</given-names></name>; <name><surname>Binda</surname><given-names>E.</given-names></name> (<year>2020</year>) <article-title>New molecular tools for regulation and improvement of A40926 glycopeptide
antibiotic production in <italic>Nonomuraea gerenzanensis</italic> ATCC 39727</article-title>. <source>Front. Microbiol.</source>
<volume>11</volume>, <fpage>8</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2020.00008</pub-id>.<pub-id pub-id-type="pmid">32038594</pub-id></mixed-citation></ref><ref id="ref7"><mixed-citation publication-type="journal" id="cit7"><name><surname>Yue</surname><given-names>X.</given-names></name>; <name><surname>Xia</surname><given-names>T.</given-names></name>; <name><surname>Wang</surname><given-names>S.</given-names></name>; <name><surname>Dong</surname><given-names>H.</given-names></name>; <name><surname>Li</surname><given-names>Y.</given-names></name> (<year>2020</year>) <article-title>Highly efficient genome
editing in <italic>N. gerenzanensis</italic> using an inducible CRISPR/Cas9&#x02013;RecA
system</article-title>. <source>Biotechnol. Lett.</source>
<volume>42</volume>, <fpage>1699</fpage>&#x02013;<lpage>1706</lpage>. <pub-id pub-id-type="doi">10.1007/s10529-020-02893-2</pub-id>.<pub-id pub-id-type="pmid">32314149</pub-id></mixed-citation></ref><ref id="ref8"><mixed-citation publication-type="journal" id="cit8"><name><surname>Nicolaou</surname><given-names>K. C.</given-names></name>; <name><surname>Boddy</surname><given-names>C. N. C.</given-names></name>; <name><surname>Br&#x000e4;se</surname><given-names>S.</given-names></name>; <name><surname>Winssinger</surname><given-names>N.</given-names></name> (<year>1999</year>) <article-title>Chemistry,
biology, and medicine of the glycopeptide antibiotics</article-title>. <source>Angew. Chem., Int. Ed.</source>
<volume>38</volume>, <fpage>2096</fpage>&#x02013;<lpage>2152</lpage>. <pub-id pub-id-type="doi">10.1002/(SICI)1521-3773(19990802)38:15&#x0003c;2096::AID-ANIE2096&#x0003e;3.0.CO;2-F</pub-id>.</mixed-citation></ref><ref id="ref9"><mixed-citation publication-type="journal" id="cit9"><name><surname>Goldstein</surname><given-names>B. P.</given-names></name>; <name><surname>Selva</surname><given-names>E.</given-names></name>; <name><surname>Gastaldo</surname><given-names>L.</given-names></name>; <name><surname>Berti</surname><given-names>M.</given-names></name>; <name><surname>Pallanza</surname><given-names>R.</given-names></name>; <name><surname>Ripamonti</surname><given-names>F.</given-names></name>; <name><surname>Ferrari</surname><given-names>P.</given-names></name>; <name><surname>Denaro</surname><given-names>M.</given-names></name>; <name><surname>Arioli</surname><given-names>V.</given-names></name>; <name><surname>Cassani</surname><given-names>G.</given-names></name> (<year>1987</year>) <article-title>A40926, a
new glycopeptide antibiotic with anti-<italic>Neisseria</italic> activity</article-title>. <source>Antimicrob. Agents
Chemother.</source>
<volume>31</volume>, <fpage>1961</fpage>&#x02013;<lpage>1966</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.31.12.1961</pub-id>.<pub-id pub-id-type="pmid">2964225</pub-id></mixed-citation></ref><ref id="ref10"><mixed-citation publication-type="journal" id="cit10"><name><surname>Marcone</surname><given-names>G. L.</given-names></name>; <name><surname>Binda</surname><given-names>E.</given-names></name>; <name><surname>Berini</surname><given-names>F.</given-names></name>; <name><surname>Marinelli</surname><given-names>F.</given-names></name> (<year>2018</year>) <article-title>Old and new
glycopeptide antibiotics: from product to gene and back in the post-genomic
era</article-title>. <source>Biotechnol. Adv.</source>
<volume>36</volume>, <fpage>534</fpage>&#x02013;<lpage>554</lpage>. <pub-id pub-id-type="doi">10.1016/j.biotechadv.2018.02.009</pub-id>.<pub-id pub-id-type="pmid">29454983</pub-id></mixed-citation></ref><ref id="ref11"><mixed-citation publication-type="journal" id="cit11"><name><surname>Yushchuk</surname><given-names>O.</given-names></name>; <name><surname>Ostash</surname><given-names>B.</given-names></name>; <name><surname>Truman</surname><given-names>A. W.</given-names></name>; <name><surname>Marinelli</surname><given-names>F.</given-names></name>; <name><surname>Fedorenko</surname><given-names>V.</given-names></name> (<year>2020</year>) <article-title>Teicoplanin biosynthesis: unraveling
the interplay
of structural, regulatory, and resistance genes</article-title>. <source>Appl. Microbiol. Biotechnol.</source>
<volume>104</volume>, <fpage>3279</fpage>&#x02013;<lpage>3291</lpage>. <pub-id pub-id-type="doi">10.1007/s00253-020-10436-y</pub-id>.<pub-id pub-id-type="pmid">32076781</pub-id></mixed-citation></ref><ref id="ref12"><mixed-citation publication-type="journal" id="cit12"><name><surname>Grundy</surname><given-names>W. E.</given-names></name>; <name><surname>Sinclair</surname><given-names>A. C.</given-names></name>; <name><surname>Theriault</surname><given-names>R. J.</given-names></name>; <name><surname>Goldstein</surname><given-names>A. W.</given-names></name>; <name><surname>Rickher</surname><given-names>C. J.</given-names></name>; <name><surname>Warren</surname><given-names>H. B.</given-names></name>; <name><surname>Oliver</surname><given-names>T. J.</given-names></name>; <name><surname>Sylvester</surname><given-names>J. C.</given-names></name> (<year>1956</year>) <article-title>Ristocetin,
microbiologic properties</article-title>. <source>Antibiot. Annu.</source>
<fpage>687</fpage>&#x02013;<lpage>692</lpage>.<pub-id pub-id-type="pmid">13425450</pub-id></mixed-citation></ref><ref id="ref13"><mixed-citation publication-type="journal" id="cit13"><name><surname>Truman</surname><given-names>A. W.</given-names></name>; <name><surname>Kwun</surname><given-names>M. J.</given-names></name>; <name><surname>Cheng</surname><given-names>J.</given-names></name>; <name><surname>Yang</surname><given-names>S. H.</given-names></name>; <name><surname>Suh</surname><given-names>J. W.</given-names></name>; <name><surname>Hong</surname><given-names>H. J.</given-names></name> (<year>2014</year>) <article-title>Antibiotic resistance mechanisms inform discovery:
identification and characterization of a novel <italic>Amycolatopsis</italic> strain producing ristocetin</article-title>. <source>Antimicrob. Agents
Chemother.</source>
<volume>58</volume>, <fpage>5687</fpage>&#x02013;<lpage>5695</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.03349-14</pub-id>.<pub-id pub-id-type="pmid">25022591</pub-id></mixed-citation></ref><ref id="ref14"><mixed-citation publication-type="journal" id="cit14"><name><surname>Spohn</surname><given-names>M.</given-names></name>; <name><surname>Kirchner</surname><given-names>N.</given-names></name>; <name><surname>Kulik</surname><given-names>A.</given-names></name>; <name><surname>Jochim</surname><given-names>A.</given-names></name>; <name><surname>Wolf</surname><given-names>F.</given-names></name>; <name><surname>Muenzer</surname><given-names>P.</given-names></name>; <name><surname>Borst</surname><given-names>O.</given-names></name>; <name><surname>Gross</surname><given-names>H.</given-names></name>; <name><surname>Wohlleben</surname><given-names>W.</given-names></name>; <name><surname>Stegmann</surname><given-names>E.</given-names></name> (<year>2014</year>) <article-title>Overproduction of ristomycin a by activation of a silent
gene cluster in <italic>Amycolatopsis japonicum</italic> MG417-CF17</article-title>. <source>Antimicrob. Agents Chemother.</source>
<volume>58</volume>, <fpage>6185</fpage>&#x02013;<lpage>6196</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.03512-14</pub-id>.<pub-id pub-id-type="pmid">25114137</pub-id></mixed-citation></ref><ref id="ref15"><mixed-citation publication-type="journal" id="cit15"><name><surname>Sosio</surname><given-names>M.</given-names></name>; <name><surname>Canavesi</surname><given-names>A.</given-names></name>; <name><surname>Stinchi</surname><given-names>S.</given-names></name>; <name><surname>Donadio</surname><given-names>S.</given-names></name> (<year>2010</year>) <article-title>Improved production
of A40926 by <italic>Nonomuraea</italic> sp. through deletion of a
pathway-specific acetyltransferase</article-title>. <source>Appl. Microbiol.
Biotechnol.</source>
<volume>87</volume>, <fpage>1633</fpage>&#x02013;<lpage>1638</lpage>. <pub-id pub-id-type="doi">10.1007/s00253-010-2579-2</pub-id>.<pub-id pub-id-type="pmid">20414653</pub-id></mixed-citation></ref><ref id="ref16"><mixed-citation publication-type="journal" id="cit16"><name><surname>Alt</surname><given-names>S.</given-names></name>; <name><surname>Bernasconi</surname><given-names>A.</given-names></name>; <name><surname>Sosio</surname><given-names>M.</given-names></name>; <name><surname>Brunati</surname><given-names>C.</given-names></name>; <name><surname>Donadio</surname><given-names>S.</given-names></name>; <name><surname>Maffioli</surname><given-names>S. I.</given-names></name> (<year>2019</year>) <article-title>Toward
single-peak dalbavancin analogs through biology
and chemistry</article-title>. <source>ACS Chem. Biol.</source>
<volume>14</volume>, <fpage>356</fpage>&#x02013;<lpage>360</lpage>. <pub-id pub-id-type="doi">10.1021/acschembio.9b00050</pub-id>.<pub-id pub-id-type="pmid">30830742</pub-id></mixed-citation></ref><ref id="ref17"><mixed-citation publication-type="journal" id="cit17"><name><surname>Soriano</surname><given-names>A.</given-names></name>; <name><surname>Rossolini</surname><given-names>G. M.</given-names></name>; <name><surname>Pea</surname><given-names>F.</given-names></name> (<year>2020</year>) <article-title>The role of dalbavancin in the treatment
of acute bacterial skin and skin structure infections (ABSSSIs)</article-title>. <source>Expert Rev. Anti-Infect. Ther.</source>
<volume>18</volume>, <fpage>415</fpage>&#x02013;<lpage>422</lpage>. <pub-id pub-id-type="doi">10.1080/14787210.2020.1746643</pub-id>.<pub-id pub-id-type="pmid">32223465</pub-id></mixed-citation></ref><ref id="ref18"><mixed-citation publication-type="journal" id="cit18"><name><surname>Sosio</surname><given-names>M.</given-names></name>; <name><surname>Stinchi</surname><given-names>S.</given-names></name>; <name><surname>Beltrametti</surname><given-names>F.</given-names></name>; <name><surname>Lazzarini</surname><given-names>A.</given-names></name>; <name><surname>Donadio</surname><given-names>S.</given-names></name> (<year>2003</year>) <article-title>The gene cluster for the biosynthesis
of the glycopeptide
antibiotic A40926 by <italic>Nonomuraea</italic> species</article-title>. <source>Chem. Biol.</source>
<volume>10</volume>, <fpage>541</fpage>&#x02013;<lpage>549</lpage>. <pub-id pub-id-type="doi">10.1016/S1074-5521(03)00120-0</pub-id>.<pub-id pub-id-type="pmid">12837387</pub-id></mixed-citation></ref><ref id="ref19"><mixed-citation publication-type="journal" id="cit19"><name><surname>Li</surname><given-names>Y. S.</given-names></name>; <name><surname>Ho</surname><given-names>J. Y.</given-names></name>; <name><surname>Huang</surname><given-names>C. C.</given-names></name>; <name><surname>Lyu</surname><given-names>S. Y.</given-names></name>; <name><surname>Lee</surname><given-names>C. Y.</given-names></name>; <name><surname>Huang</surname><given-names>Y. T.</given-names></name>; <name><surname>Wu</surname><given-names>C. J.</given-names></name>; <name><surname>Chan</surname><given-names>H. C.</given-names></name>; <name><surname>Huang</surname><given-names>C. J.</given-names></name>; <name><surname>Hsu</surname><given-names>N. S.</given-names></name>; <name><surname>Tsai</surname><given-names>M. D.</given-names></name>; <name><surname>Li</surname><given-names>T. L.</given-names></name> (<year>2007</year>) <article-title>A unique
flavin
mononucleotide-linked primary alcohol oxidase for glycopeptide A40926
maturation</article-title>. <source>J. Am. Chem. Soc.</source>
<volume>129</volume>, <fpage>13384</fpage>&#x02013;<lpage>13385</lpage>. <pub-id pub-id-type="doi">10.1021/ja075748x</pub-id>.<pub-id pub-id-type="pmid">17935335</pub-id></mixed-citation></ref><ref id="ref20"><mixed-citation publication-type="journal" id="cit20"><name><surname>Kaniusaite</surname><given-names>M.</given-names></name>; <name><surname>Tailhades</surname><given-names>J.</given-names></name>; <name><surname>Kittil&#x000e4;</surname><given-names>T.</given-names></name>; <name><surname>Fage</surname><given-names>C. D.</given-names></name>; <name><surname>Goode</surname><given-names>R. J. A.</given-names></name>; <name><surname>Schittenhelm</surname><given-names>R. B.</given-names></name>; <name><surname>Cryle</surname><given-names>M. J.</given-names></name> (<year>2021</year>) <article-title>Understanding the
early stages of peptide formation during the biosynthesis of teicoplanin
and related glycopeptide antibiotics</article-title>. <source>FEBS J.</source>
<volume>288</volume>, <fpage>507</fpage>&#x02013;<lpage>529</lpage>. <pub-id pub-id-type="doi">10.1111/febs.15350</pub-id>.<pub-id pub-id-type="pmid">32359003</pub-id></mixed-citation></ref><ref id="ref21"><mixed-citation publication-type="journal" id="cit21"><name><surname>Binda</surname><given-names>E.</given-names></name>; <name><surname>Marcone</surname><given-names>G. L.</given-names></name>; <name><surname>Pollegioni</surname><given-names>L.</given-names></name>; <name><surname>Marinelli</surname><given-names>F.</given-names></name> (<year>2012</year>) <article-title>Characterization
of VanYn, a novel <sc>D</sc>,<sc>D</sc>-peptidase/D,D-carboxypeptidase
involved in glycopeptide antibiotic resistance in <italic>Nonomuraea</italic> sp. ATCC 39727</article-title>. <source>FEBS J.</source>
<volume>279</volume>, <fpage>3203</fpage>&#x02013;<lpage>3213</lpage>. <pub-id pub-id-type="doi">10.1111/j.1742-4658.2012.08706.x</pub-id>.<pub-id pub-id-type="pmid">22788848</pub-id></mixed-citation></ref><ref id="ref22"><mixed-citation publication-type="journal" id="cit22"><name><surname>Marcone</surname><given-names>G. L.</given-names></name>; <name><surname>Binda</surname><given-names>E.</given-names></name>; <name><surname>Carrano</surname><given-names>L.</given-names></name>; <name><surname>Bibb</surname><given-names>M.</given-names></name>; <name><surname>Marinelli</surname><given-names>F.</given-names></name> (<year>2014</year>) <article-title>Relationship
between glycopeptide production and resistance in the actinomycete <italic>Nonomuraea</italic> sp. ATCC 39727</article-title>. <source>Antimicrob.
Agents Chemother.</source>
<volume>58</volume>, <fpage>5191</fpage>&#x02013;<lpage>5201</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.02626-14</pub-id>.<pub-id pub-id-type="pmid">24957828</pub-id></mixed-citation></ref><ref id="ref23"><mixed-citation publication-type="journal" id="cit23"><name><surname>Lo
Grasso</surname><given-names>L.</given-names></name>; <name><surname>Maffioli</surname><given-names>S.</given-names></name>; <name><surname>Sosio</surname><given-names>M.</given-names></name>; <name><surname>Bibb</surname><given-names>M.</given-names></name>; <name><surname>Puglia</surname><given-names>A. M.</given-names></name>; <name><surname>Alduina</surname><given-names>R.</given-names></name> (<year>2015</year>) <article-title>Two master switch regulators trigger
A40926 biosynthesis in <italic>Nonomuraea</italic> sp. strain ATCC
39727</article-title>. <source>J. Bacteriol.</source>
<volume>197</volume>, <fpage>2536</fpage>&#x02013;<lpage>2544</lpage>. <pub-id pub-id-type="doi">10.1128/JB.00262-15</pub-id>.<pub-id pub-id-type="pmid">25986904</pub-id></mixed-citation></ref><ref id="ref24"><mixed-citation publication-type="journal" id="cit24"><name><surname>Alduina</surname><given-names>R.</given-names></name>; <name><surname>Tocchetti</surname><given-names>A.</given-names></name>; <name><surname>Costa</surname><given-names>S.</given-names></name>; <name><surname>Ferraro</surname><given-names>C.</given-names></name>; <name><surname>Cancemi</surname><given-names>P.</given-names></name>; <name><surname>Sosio</surname><given-names>M.</given-names></name>; <name><surname>Donadio</surname><given-names>S.</given-names></name> (<year>2020</year>) <article-title>A two-component regulatory system
with opposite effects on glycopeptide antibiotic biosynthesis and
resistance</article-title>. <source>Sci. Rep.</source>
<volume>10</volume>, <fpage>6200</fpage><pub-id pub-id-type="doi">10.1038/s41598-020-63257-4</pub-id>.<pub-id pub-id-type="pmid">32277112</pub-id></mixed-citation></ref><ref id="ref25"><mixed-citation publication-type="journal" id="cit25"><name><surname>Naruse</surname><given-names>N.</given-names></name>; <name><surname>Tenmyo</surname><given-names>O.</given-names></name>; <name><surname>Kobaru</surname><given-names>S.</given-names></name>; <name><surname>Hatori</surname><given-names>M.</given-names></name>; <name><surname>Tomita</surname><given-names>K.</given-names></name>; <name><surname>Hamagishi</surname><given-names>Y.</given-names></name>; <name><surname>Oki</surname><given-names>T.</given-names></name> (<year>1993</year>) <article-title>New antiviral antibiotics,
kistamicins
A and B I. Taxonomy, production, isolation, physico-chemical properties
and biological activities</article-title>. <source>J. Antibiot.</source>
<volume>46</volume>, <fpage>1804</fpage>&#x02013;<lpage>1811</lpage>. <pub-id pub-id-type="doi">10.7164/antibiotics.46.1804</pub-id>.</mixed-citation></ref><ref id="ref26"><mixed-citation publication-type="journal" id="cit26"><name><surname>Naruse</surname><given-names>N.</given-names></name>; <name><surname>Oka</surname><given-names>M.</given-names></name>; <name><surname>Konishi</surname><given-names>M.</given-names></name>; <name><surname>Oki</surname><given-names>T.</given-names></name> (<year>1993</year>) <article-title>New Antiviral Antibiotics, Kistamicins
A and B II. Structure determination</article-title>. <source>J. Antibiot.</source>
<volume>46</volume>, <fpage>1812</fpage>&#x02013;<lpage>1818</lpage>. <pub-id pub-id-type="doi">10.7164/antibiotics.46.1812</pub-id>.</mixed-citation></ref><ref id="ref27"><mixed-citation publication-type="journal" id="cit27"><name><surname>Waglechner</surname><given-names>N.</given-names></name>; <name><surname>McArthur</surname><given-names>A. G.</given-names></name>; <name><surname>Wright</surname><given-names>G. D.</given-names></name> (<year>2019</year>) <article-title>Phylogenetic
reconciliation reveals
the natural history of glycopeptide antibiotic biosynthesis and resistance</article-title>. <source>Nat. Microbiol.</source>
<volume>4</volume>, <fpage>1862</fpage>&#x02013;<lpage>1871</lpage>. <pub-id pub-id-type="doi">10.1038/s41564-019-0531-5</pub-id>.<pub-id pub-id-type="pmid">31406334</pub-id></mixed-citation></ref><ref id="ref28"><mixed-citation publication-type="journal" id="cit28"><name><surname>Malabarba</surname><given-names>A.</given-names></name>; <name><surname>Ciabatti</surname><given-names>R.</given-names></name>; <name><surname>Scotti</surname><given-names>R.</given-names></name>; <name><surname>Goldstein</surname><given-names>B. P.</given-names></name>; <name><surname>Ferrari</surname><given-names>P.</given-names></name>; <name><surname>Kurz</surname><given-names>M.</given-names></name>; <name><surname>Andreini</surname><given-names>B. P.</given-names></name>; <name><surname>Denaro</surname><given-names>M.</given-names></name> (<year>1995</year>) <article-title>New semisynthetic
glycopeptides MDL 63,246 and MDL 63,042, and other amide derivatives
of antibiotic A-40,926 active against highly glycopeptide-resistant
VanA enterococci</article-title>. <source>J. Antibiot.</source>
<volume>48</volume>, <fpage>869</fpage>&#x02013;<lpage>883</lpage>. <pub-id pub-id-type="doi">10.7164/antibiotics.48.869</pub-id>.</mixed-citation></ref><ref id="ref29"><mixed-citation publication-type="journal" id="cit29"><name><surname>Blin</surname><given-names>K.</given-names></name>; <name><surname>Shaw</surname><given-names>S.</given-names></name>; <name><surname>Steinke</surname><given-names>K.</given-names></name>; <name><surname>Villebro</surname><given-names>R.</given-names></name>; <name><surname>Ziemert</surname><given-names>N.</given-names></name>; <name><surname>Lee</surname><given-names>S. Y.</given-names></name>; <name><surname>Medema</surname><given-names>M. H.</given-names></name>; <name><surname>Weber</surname><given-names>T.</given-names></name> (<year>2019</year>) <article-title>AntiSMASH 5.0: Updates
to the secondary metabolite genome mining pipeline</article-title>. <source>Nucleic Acids Res.</source>
<volume>47</volume>, <fpage>W81</fpage>&#x02013;<lpage>W87</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkz310</pub-id>.<pub-id pub-id-type="pmid">31032519</pub-id></mixed-citation></ref><ref id="ref30"><mixed-citation publication-type="journal" id="cit30"><name><surname>Adamek</surname><given-names>M.</given-names></name>; <name><surname>Alanjary</surname><given-names>M.</given-names></name>; <name><surname>Sales-Ortells</surname><given-names>H.</given-names></name>; <name><surname>Goodfellow</surname><given-names>M.</given-names></name>; <name><surname>Bull</surname><given-names>A. T.</given-names></name>; <name><surname>Winkler</surname><given-names>A.</given-names></name>; <name><surname>Wibberg</surname><given-names>D.</given-names></name>; <name><surname>Kalinowski</surname><given-names>J.</given-names></name>; <name><surname>Ziemert</surname><given-names>N.</given-names></name> (<year>2018</year>) <article-title>Comparative genomics reveals phylogenetic distribution
patterns of secondary metabolites in <italic>Amycolatopsis</italic> species</article-title>. <source>BMC Genomics</source>
<volume>19</volume>, <fpage>426</fpage><pub-id pub-id-type="doi">10.1186/s12864-018-4809-4</pub-id>.<pub-id pub-id-type="pmid">29859036</pub-id></mixed-citation></ref><ref id="ref31"><mixed-citation publication-type="journal" id="cit31"><name><surname>Darling</surname><given-names>A. C. E.</given-names></name>; <name><surname>Mau</surname><given-names>B.</given-names></name>; <name><surname>Blattner</surname><given-names>F. R.</given-names></name>; <name><surname>Perna</surname><given-names>N. T.</given-names></name> (<year>2004</year>) <article-title>MAUVE:
multiple
alignment of conserved genomic sequence with rearrangements</article-title>. <source>Genome Res.</source>
<volume>14</volume>, <fpage>1394</fpage>&#x02013;<lpage>1403</lpage>. <pub-id pub-id-type="doi">10.1101/gr.2289704</pub-id>.<pub-id pub-id-type="pmid">15231754</pub-id></mixed-citation></ref><ref id="ref32"><mixed-citation publication-type="journal" id="cit32"><name><surname>Alduina</surname><given-names>R.</given-names></name>; <name><surname>Sosio</surname><given-names>M.</given-names></name>; <name><surname>Donadio</surname><given-names>S.</given-names></name> (<year>2018</year>) <article-title>Complex regulatory networks governing
production of the glycopeptide A40926</article-title>. <source>Antibiotics
(Basel, Switz.)</source>
<volume>7</volume>, <fpage>30</fpage><pub-id pub-id-type="doi">10.3390/antibiotics7020030</pub-id>.</mixed-citation></ref><ref id="ref33"><mixed-citation publication-type="journal" id="cit33"><name><surname>Alduina</surname><given-names>R.</given-names></name>; <name><surname>Piccolo</surname><given-names>L. L.</given-names></name>; <name><surname>D'Alia</surname><given-names>D.</given-names></name>; <name><surname>Ferraro</surname><given-names>C.</given-names></name>; <name><surname>Gunnarsson</surname><given-names>N.</given-names></name>; <name><surname>Donadio</surname><given-names>S.</given-names></name>; <name><surname>Puglia</surname><given-names>A. M.</given-names></name> (<year>2007</year>) <article-title>Phosphate-controlled
regulator for
the biosynthesis of the dalbavancin precursor A40926</article-title>. <source>J. Bacteriol.</source>
<volume>189</volume>, <fpage>8120</fpage>&#x02013;<lpage>8129</lpage>. <pub-id pub-id-type="doi">10.1128/JB.01247-07</pub-id>.<pub-id pub-id-type="pmid">17873036</pub-id></mixed-citation></ref><ref id="ref34"><mixed-citation publication-type="journal" id="cit34"><name><surname>Binda</surname><given-names>E.</given-names></name>; <name><surname>Marcone</surname><given-names>G. L.</given-names></name>; <name><surname>Berini</surname><given-names>F.</given-names></name>; <name><surname>Pollegioni</surname><given-names>L.</given-names></name>; <name><surname>Marinelli</surname><given-names>F.</given-names></name> (<year>2013</year>) <article-title><italic>Streptomyces</italic> spp. as efficient expression
system for a D,D-peptidase/D,D-carboxypeptidase involved in glycopeptide
antibiotic resistance</article-title>. <source>BMC Biotechnol.</source>
<volume>13</volume>, <fpage>24</fpage><pub-id pub-id-type="doi">10.1186/1472-6750-13-24</pub-id>.<pub-id pub-id-type="pmid">23497129</pub-id></mixed-citation></ref><ref id="ref35"><mixed-citation publication-type="journal" id="cit35"><name><surname>Pootoolal</surname><given-names>J.</given-names></name>; <name><surname>Thomas</surname><given-names>M. G.</given-names></name>; <name><surname>Marshall</surname><given-names>C. G.</given-names></name>; <name><surname>Neu</surname><given-names>J. M.</given-names></name>; <name><surname>Hubbard</surname><given-names>B. K.</given-names></name>; <name><surname>Walsh</surname><given-names>C. T.</given-names></name>; <name><surname>Wright</surname><given-names>G. D.</given-names></name> (<year>2002</year>) <article-title>Assembling
the glycopeptide antibiotic
scaffold: the biosynthesis of A47934 from <italic>Streptomyces toyocaensis</italic> NRRL15009</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source>
<volume>99</volume>, <fpage>8962</fpage>&#x02013;<lpage>8967</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.102285099</pub-id>.<pub-id pub-id-type="pmid">12060705</pub-id></mixed-citation></ref><ref id="ref36"><mixed-citation publication-type="journal" id="cit36"><name><surname>Ara</surname><given-names>I.</given-names></name>; <name><surname>Kudo</surname><given-names>T.</given-names></name>; <name><surname>Matsumoto</surname><given-names>A.</given-names></name>; <name><surname>Takahashi</surname><given-names>Y.</given-names></name>; <name><surname>Omura</surname><given-names>S.</given-names></name> (<year>2007</year>) <article-title><italic>Nonomuraea bangladeshensis</italic> sp. nov. and <italic>Nonomuraea coxensis</italic> sp. nov</article-title>. <source>Int.
J. Syst. Evol. Microbiol.</source>
<volume>57</volume>, <fpage>1504</fpage>&#x02013;<lpage>1509</lpage>. <pub-id pub-id-type="doi">10.1099/ijs.0.65054-0</pub-id>.<pub-id pub-id-type="pmid">17625184</pub-id></mixed-citation></ref><ref id="ref37"><mixed-citation publication-type="journal" id="cit37"><name><surname>Marcone</surname><given-names>G. L.</given-names></name>; <name><surname>Beltrametti</surname><given-names>F.</given-names></name>; <name><surname>Binda</surname><given-names>E.</given-names></name>; <name><surname>Carrano</surname><given-names>L.</given-names></name>; <name><surname>Foulston</surname><given-names>L.</given-names></name>; <name><surname>Hesketh</surname><given-names>A.</given-names></name>; <name><surname>Bibb</surname><given-names>M.</given-names></name>; <name><surname>Marinelli</surname><given-names>F.</given-names></name> (<year>2010</year>) <article-title>Novel mechanism
of glycopeptide resistance in the A40926 producer <italic>Nonomuraea</italic> sp. ATCC 39727</article-title>. <source>Antimicrob. Agents Chemother.</source>
<volume>54</volume>, <fpage>2465</fpage>&#x02013;<lpage>2472</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.00106-10</pub-id>.<pub-id pub-id-type="pmid">20308385</pub-id></mixed-citation></ref><ref id="ref38"><mixed-citation publication-type="journal" id="cit38"><name><surname>Taurino</surname><given-names>C.</given-names></name>; <name><surname>Frattini</surname><given-names>L.</given-names></name>; <name><surname>Marcone</surname><given-names>G. L.</given-names></name>; <name><surname>Gastaldo</surname><given-names>L.</given-names></name>; <name><surname>Marinelli</surname><given-names>F.</given-names></name> (<year>2011</year>) <article-title><italic>Actinoplanes
teichomyceticus</italic> ATCC 31121 as a cell factory for producing
teicoplanin</article-title>. <source>Microb. Cell Fact.</source>
<volume>10</volume>, <fpage>82</fpage><pub-id pub-id-type="doi">10.1186/1475-2859-10-82</pub-id>.<pub-id pub-id-type="pmid">22008254</pub-id></mixed-citation></ref><ref id="ref39"><mixed-citation publication-type="journal" id="cit39"><name><surname>Puk</surname><given-names>O.</given-names></name>; <name><surname>Bischoff</surname><given-names>D.</given-names></name>; <name><surname>Kittel</surname><given-names>C.</given-names></name>; <name><surname>Pelzer</surname><given-names>S.</given-names></name>; <name><surname>Weist</surname><given-names>S.</given-names></name>; <name><surname>Stegmann</surname><given-names>E.</given-names></name>; <name><surname>S&#x000fc;ssmuth</surname><given-names>R. D.</given-names></name>; <name><surname>Wohlleben</surname><given-names>W.</given-names></name> (<year>2004</year>) <article-title>Biosynthesis
of chloro-&#x003b2;-hydroxytyrosine, a nonproteinogenic amino acid of
the peptidic backbone of glycopeptide antibiotics</article-title>. <source>J. Bacteriol.</source>
<volume>186</volume>, <fpage>6093</fpage>&#x02013;<lpage>6100</lpage>. <pub-id pub-id-type="doi">10.1128/JB.186.18.6093-6100.2004</pub-id>.<pub-id pub-id-type="pmid">15342578</pub-id></mixed-citation></ref><ref id="ref40"><mixed-citation publication-type="journal" id="cit40"><name><surname>Yushchuk</surname><given-names>O.</given-names></name>; <name><surname>Binda</surname><given-names>E.</given-names></name>; <name><surname>Marinelli</surname><given-names>F.</given-names></name> (<year>2020</year>) <article-title>Glycopeptide
antibiotic resistance
genes: distribution and function in the producer actinomycetes</article-title>. <source>Front. Microbiol.</source>
<volume>11</volume>, <fpage>1</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2020.01173</pub-id>.<pub-id pub-id-type="pmid">32082274</pub-id></mixed-citation></ref><ref id="ref41"><mixed-citation publication-type="journal" id="cit41"><name><surname>Zerilli</surname><given-names>L. F.</given-names></name>; <name><surname>Edwards</surname><given-names>D. M. F.</given-names></name>; <name><surname>Borghi</surname><given-names>A.</given-names></name>; <name><surname>Gallo</surname><given-names>G. G.</given-names></name>; <name><surname>Selva</surname><given-names>E.</given-names></name>; <name><surname>Denaro</surname><given-names>M.</given-names></name>; <name><surname>Lancini</surname><given-names>G. C.</given-names></name> (<year>1992</year>) <article-title>Determination of the acyl moieties
of the antibiotic complex A40926 and their relation with the membrane
lipids of the producer strain</article-title>. <source>Rapid Commun.
Mass Spectrom.</source>
<volume>6</volume>, <fpage>109</fpage>&#x02013;<lpage>114</lpage>. <pub-id pub-id-type="doi">10.1002/rcm.1290060208</pub-id>.<pub-id pub-id-type="pmid">1504339</pub-id></mixed-citation></ref><ref id="ref42"><mixed-citation publication-type="journal" id="cit42"><name><surname>Xu</surname><given-names>M.</given-names></name>; <name><surname>Wang</surname><given-names>W.</given-names></name>; <name><surname>Waglechner</surname><given-names>N.</given-names></name>; <name><surname>Culp</surname><given-names>E. J.</given-names></name>; <name><surname>Guitor</surname><given-names>A. K.</given-names></name>; <name><surname>Wright</surname><given-names>G. D.</given-names></name> (<year>2020</year>) <article-title>GPAHex
- a synthetic biology platform for type IV&#x02013;V
glycopeptide antibiotic production and discovery</article-title>. <source>Nat. Commun.</source>
<volume>11</volume>, <fpage>5232</fpage><pub-id pub-id-type="doi">10.1038/s41467-020-19138-5</pub-id>.<pub-id pub-id-type="pmid">33067466</pub-id></mixed-citation></ref><ref id="ref43"><mixed-citation publication-type="journal" id="cit43"><name><surname>Culp</surname><given-names>E. J.</given-names></name>; <name><surname>Waglechner</surname><given-names>N.</given-names></name>; <name><surname>Wang</surname><given-names>W.</given-names></name>; <name><surname>Fiebig-Comyn</surname><given-names>A. A.</given-names></name>; <name><surname>Hsu</surname><given-names>Y. P.</given-names></name>; <name><surname>Koteva</surname><given-names>K.</given-names></name>; <name><surname>Sychantha</surname><given-names>D.</given-names></name>; <name><surname>Coombes</surname><given-names>B. K.</given-names></name>; <name><surname>Van Nieuwenhze</surname><given-names>M. S.</given-names></name>; <name><surname>Brun</surname><given-names>Y. V.</given-names></name>; <name><surname>Wright</surname><given-names>G. D.</given-names></name> (<year>2020</year>) <article-title>Evolution-guided
discovery of antibiotics that inhibit peptidoglycan remodelling</article-title>. <source>Nature</source>
<volume>578</volume>, <fpage>582</fpage>&#x02013;<lpage>587</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-020-1990-9</pub-id>.<pub-id pub-id-type="pmid">32051588</pub-id></mixed-citation></ref><ref id="ref44"><mixed-citation publication-type="journal" id="cit44"><name><surname>Horbal</surname><given-names>L.</given-names></name>; <name><surname>Kobylyanskyy</surname><given-names>A.</given-names></name>; <name><surname>Yushchuk</surname><given-names>O.</given-names></name>; <name><surname>Zaburannyi</surname><given-names>N.</given-names></name>; <name><surname>Luzhetskyy</surname><given-names>A.</given-names></name>; <name><surname>Ostash</surname><given-names>B.</given-names></name>; <name><surname>Marinelli</surname><given-names>F.</given-names></name>; <name><surname>Fedorenko</surname><given-names>V.</given-names></name> (<year>2013</year>) <article-title>Evaluation of heterologous promoters for genetic analysis
of <italic>Actinoplanes teichomyceticus</italic> - producer of teicoplanin,
drug of last defense</article-title>. <source>J. Biotechnol.</source>
<volume>168</volume>, <fpage>367</fpage>&#x02013;<lpage>372</lpage>. <pub-id pub-id-type="doi">10.1016/j.jbiotec.2013.10.018</pub-id>.<pub-id pub-id-type="pmid">24161919</pub-id></mixed-citation></ref><ref id="ref45"><mixed-citation publication-type="journal" id="cit45"><name><surname>Horbal</surname><given-names>L.</given-names></name>; <name><surname>Kobylyanskyy</surname><given-names>A.</given-names></name>; <name><surname>Truman</surname><given-names>A. W.</given-names></name>; <name><surname>Zaburranyi</surname><given-names>N.</given-names></name>; <name><surname>Ostash</surname><given-names>B.</given-names></name>; <name><surname>Luzhetskyy</surname><given-names>A.</given-names></name>; <name><surname>Marinelli</surname><given-names>F.</given-names></name>; <name><surname>Fedorenko</surname><given-names>V.</given-names></name> (<year>2014</year>) <article-title>The pathway-specific regulatory genes, <italic>tei15*</italic> and <italic>tei16*</italic>, are the master switches
of teicoplanin
production in <italic>Actinoplanes teichomyceticus</italic></article-title>. <source>Appl. Microbiol. Biotechnol.</source>
<volume>98</volume>, <fpage>9295</fpage>&#x02013;<lpage>9309</lpage>. <pub-id pub-id-type="doi">10.1007/s00253-014-5969-z</pub-id>.<pub-id pub-id-type="pmid">25104028</pub-id></mixed-citation></ref><ref id="ref46"><mixed-citation publication-type="book" id="cit46"><person-group person-group-type="allauthors"><name><surname>Kieser</surname><given-names>T.</given-names></name>, <name><surname>Bibb</surname><given-names>M.
J.</given-names></name>, <name><surname>Buttner</surname><given-names>M. J.</given-names></name>, <name><surname>Chater</surname><given-names>K. F.</given-names></name>, and <name><surname>Hopwood</surname><given-names>D. A.</given-names></name></person-group> (<year>2000</year>) <source>Practical Streptomyces genetics</source>; <publisher-name>John Innes
Foundation</publisher-name>, <publisher-loc>Norwich, England</publisher-loc>.</mixed-citation></ref><ref id="ref47"><mixed-citation publication-type="journal" id="cit47"><name><surname>Holding</surname><given-names>A. N.</given-names></name>; <name><surname>Spencer</surname><given-names>J. B.</given-names></name> (<year>2008</year>) <article-title>Investigation into
the mechanism of phenolic couplings
during the biosynthesis of glycopeptide antibiotics</article-title>. <source>ChemBioChem</source>
<volume>9</volume>, <fpage>2209</fpage>&#x02013;<lpage>2214</lpage>. <pub-id pub-id-type="doi">10.1002/cbic.200800303</pub-id>.<pub-id pub-id-type="pmid">18677741</pub-id></mixed-citation></ref><ref id="ref48"><mixed-citation publication-type="journal" id="cit48"><name><surname>Bekiesch</surname><given-names>P.</given-names></name>; <name><surname>Zehl</surname><given-names>M.</given-names></name>; <name><surname>Domingo-Contreras</surname><given-names>E.</given-names></name>; <name><surname>Mart&#x000ed;n</surname><given-names>J.</given-names></name>; <name><surname>P&#x000e9;rez-Victoria</surname><given-names>I.</given-names></name>; <name><surname>Reyes</surname><given-names>F.</given-names></name>; <name><surname>Kaplan</surname><given-names>A.</given-names></name>; <name><surname>R&#x000fc;ckert</surname><given-names>C.</given-names></name>; <name><surname>Busche</surname><given-names>T.</given-names></name>; <name><surname>Kalinowski</surname><given-names>J.</given-names></name>; <name><surname>Zotchev</surname><given-names>S. B.</given-names></name> (<year>2020</year>) <article-title>Viennamycins: lipopeptides produced by a <italic>Streptomyces</italic> sp</article-title>. <source>J. Nat. Prod.</source>
<volume>83</volume>, <fpage>2381</fpage>&#x02013;<lpage>2389</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jnatprod.0c00152</pub-id>.<pub-id pub-id-type="pmid">32786880</pub-id></mixed-citation></ref><ref id="ref49"><mixed-citation publication-type="journal" id="cit49"><name><surname>Gordon</surname><given-names>D.</given-names></name>; <name><surname>Green</surname><given-names>P.</given-names></name> (<year>2013</year>) <article-title>Consed: A Graphical
editor for next-generation sequencing</article-title>. <source>Bioinformatics</source>
<volume>29</volume>, <fpage>2936</fpage>&#x02013;<lpage>2937</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btt515</pub-id>.<pub-id pub-id-type="pmid">23995391</pub-id></mixed-citation></ref><ref id="ref50"><mixed-citation publication-type="journal" id="cit50"><name><surname>Seemann</surname><given-names>T.</given-names></name> (<year>2014</year>) <article-title>Prokka: rapid
prokaryotic genome annotation</article-title>. <source>Bioinformatics</source>
<volume>30</volume>, <fpage>2068</fpage>&#x02013;<lpage>2069</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btu153</pub-id>.<pub-id pub-id-type="pmid">24642063</pub-id></mixed-citation></ref><ref id="ref51"><mixed-citation publication-type="journal" id="cit51"><name><surname>Kearse</surname><given-names>M.</given-names></name>; <name><surname>Moir</surname><given-names>R.</given-names></name>; <name><surname>Wilson</surname><given-names>A.</given-names></name>; <name><surname>Stones-Havas</surname><given-names>S.</given-names></name>; <name><surname>Cheung</surname><given-names>M.</given-names></name>; <name><surname>Sturrock</surname><given-names>S.</given-names></name>; <name><surname>Buxton</surname><given-names>S.</given-names></name>; <name><surname>Cooper</surname><given-names>A.</given-names></name>; <name><surname>Markowitz</surname><given-names>S.</given-names></name>; <name><surname>Duran</surname><given-names>C.</given-names></name>; <name><surname>Thierer</surname><given-names>T.</given-names></name>; <name><surname>Ashton</surname><given-names>B.</given-names></name>; <name><surname>Meintjes</surname><given-names>P.</given-names></name>; <name><surname>Drummond</surname><given-names>A.</given-names></name> (<year>2012</year>) <article-title>Geneious basic: an
integrated and
extendable desktop software platform for the organization and analysis
of sequence data</article-title>. <source>Bioinformatics</source>
<volume>28</volume>, <fpage>1647</fpage>&#x02013;<lpage>1649</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/bts199</pub-id>.<pub-id pub-id-type="pmid">22543367</pub-id></mixed-citation></ref><ref id="ref52"><mixed-citation publication-type="journal" id="cit52"><name><surname>Kumar</surname><given-names>S.</given-names></name>; <name><surname>Stecher</surname><given-names>G.</given-names></name>; <name><surname>Li</surname><given-names>M.</given-names></name>; <name><surname>Knyaz</surname><given-names>C.</given-names></name>; <name><surname>Tamura</surname><given-names>K.</given-names></name> (<year>2018</year>) <article-title>MEGA X: molecular
evolutionary genetics analysis across computing platforms</article-title>. <source>Mol. Biol. Evol.</source>
<volume>35</volume>, <fpage>1547</fpage>&#x02013;<lpage>1549</lpage>. <pub-id pub-id-type="doi">10.1093/molbev/msy096</pub-id>.<pub-id pub-id-type="pmid">29722887</pub-id></mixed-citation></ref><ref id="ref53"><mixed-citation publication-type="journal" id="cit53"><name><surname>Gao</surname><given-names>B.</given-names></name>; <name><surname>Gupta</surname><given-names>R. S.</given-names></name> (<year>2012</year>) <article-title>Phylogenetic framework and molecular signatures for
the main clades of the phylum Actinobacteria</article-title>. <source>Microbiol. Mol. Biol. Rev.</source>
<volume>76</volume>, <fpage>66</fpage>&#x02013;<lpage>112</lpage>. <pub-id pub-id-type="doi">10.1128/MMBR.05011-11</pub-id>.<pub-id pub-id-type="pmid">22390973</pub-id></mixed-citation></ref></ref-list></back></article>